Mississippi State University

Scholars Junction
Theses and Dissertations

Theses and Dissertations

5-4-2018

Serum banking of the Mississippi shelter dog population to
estimate seroprevalence of diseases affecting animal and human
health
Kristina Hubbard

Follow this and additional works at: https://scholarsjunction.msstate.edu/td

Recommended Citation
Hubbard, Kristina, "Serum banking of the Mississippi shelter dog population to estimate seroprevalence
of diseases affecting animal and human health" (2018). Theses and Dissertations. 3925.
https://scholarsjunction.msstate.edu/td/3925

This Graduate Thesis - Open Access is brought to you for free and open access by the Theses and Dissertations at
Scholars Junction. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of
Scholars Junction. For more information, please contact scholcomm@msstate.libanswers.com.

Template B v3.0 (beta): Created by J. Nail 06/2015

Serum banking of the Mississippi shelter dog population to estimate seroprevalence of
diseases affecting animal and human health

By
TITLE PAGE
Kristina Hubbard

A Thesis
Submitted to the Faculty of
Mississippi State University
in Partial Fulfillment of the Requirements
for the Degree of Master of Science
in Population Medicine - Thesis
in the College of Veterinary Medicine
Mississippi State, Mississippi
May 2018

Copyright by
COPYRIGHT PAGE
Kristina Hubbard
2018

Serum banking of the Mississippi shelter dog population to estimate seroprevalence of
diseases affecting animal and human health
By
APPROVAL PAGE
Kristina Hubbard
Approved:
____________________________________
David R. Smith
(Major Professor)
____________________________________
Robert W. Wills
(Committee Member)
____________________________________
Carla L. Huston
(Committee Member)
____________________________________
Larry A. Hanson
(Graduate Coordinator)
____________________________________
Mark L. Lawrence
Associate Dean for Research and Graduate Studies
College of Veterinary Medicine

Name: Kristina Hubbard
ABSTRACT
Date of Degree: May 4, 2018
Institution: Mississippi State University
Major Field: Population Medicine - Thesis
Major Professor: David R. Smith
Title of Study: Serum banking of the Mississippi shelter dog population to estimate
seroprevalence of diseases affecting animal and human health
Pages in Study 132
Candidate for Degree of Master of Science
Shelter dog populations in the United States are poorly quantified and
characterized, but may be effective targets for measuring the occurrence of select
diseases affecting animal and human health. Dogs in this population may have increased
risk for disease due to intrinsic and extrinsic risk factors. Accurate estimates of disease in
this population require sound sampling strategies within a comprehensive sampling
frame.
Knowledge of the prevalence of disease in the Mississippi shelter dog population
is important for diagnostic test interpretation, shelter allocation of resources, and public
health risk assessment. A serum bank provides a valuable resource to investigate both
zoonotic diseases in which dogs are the primary reservoir, such as canine brucellosis, and
for diseases where dogs may be effective sentinels for exposure risk, such as American
trypanosomiasis. Implications of this research extend beyond Mississippi through the
frequent movement of shelter dogs to adoption centers across the United States.
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CHAPTER I
LITERATURE REVIEW
Shelter dog population characteristics and disease epidemiology
Shelter dogs pose unique challenges and opportunities for disease research. This
population is poorly defined with complex movement dynamics, which complicates
sampling methods to measure disease prevalence. Several intrinsic and extrinsic risk
factors have been proposed to explain different rates of infectious disease seen between
shelter dogs and the owned dog population, however, there is little research validating
these assumptions. Increased knowledge of the determinants and occurrence of disease is
important for animal shelter management and public health risk assessment, with shelter
dogs potentially serving both as sources of zoonotic infection as well as useful sentinels
for disease.
Estimating dog populations
Estimates of the numbers of both the owned and shelter dog populations in the
United States are widely quoted, but lack consistency and are subject to sample bias. The
American Veterinary Medical Association (AVMA) releases nationwide statistics
compiled approximately every 5 years, including the percent of US households owning
pet species and the average number of pets in each household. The most recent survey,
released in 2012, estimated 69.9 million dogs in 43.3 million homes.1 Similarly, the
American Pet Products Association (APPA) performs a periodic national survey to
1

estimate pet ownership and spending habits of pet owners. The 2013-2014 APPA survey
reported 83.3 million dogs in 56.7 million homes.2
Discrepancies between population estimates may be partially explained by
increasing pet ownership between sampled years, however, they more likely indicate
variability in sampling strategy and data analysis. These estimates are produced from a
small number of households selected to represent the nationwide population based on
gender, age, household size, income, and geographic region. In the most recent APPA
survey, a total of 505 completed surveys were used to determine all dog information.2
The accuracy of such estimates has frequently been challenged, both informally and
formally. Patronek and Rowan provide one review comparing AVMA estimates to
random-digit dialing performed in select areas. The national survey resulted in marked
overestimation of the dog population, and the authors cite many potentially contributing
factors including low response rates, response bias among pet owners, and selection bias
in household eligibility criteria.3
A now-dated review by Marx and Furcolow found only 6 dog population studies
in the United States which could be compared on the basis of data collected and sampling
method. They report an owned dog-to-human ratio range of 1:4.7 to 1:13.7, indicating
that calculation of total population numbers from such simple population characteristics
is likely to result in a large margin of error.4 Similarly, studies in select communities
indicate wide geographic variation in pet ownership trends and between urban and rural
areas.5-7
More advanced methods to estimate animal populations have also been applied to
shelter dog populations. An early extrapolation of AVMA data combined with regional
2

private data resulted in an estimated shelter dog population of 6.6 million in 1991, with
3.75 million animals euthanized.8 Patronek and Glickman developed a population
dynamics model to estimate the pet dog population, which included an estimate of 4
million dogs in animal shelters, of which, 2.4 million are euthanized.9 Capture-recapture
methodology, commonly used in ecology, has recently been applied to estimate owned
dog populations as well as the US shelter dog population.10 These methods provide more
conservative estimates consistent with the apparent downward trend in the number of
shelter dogs. Comprehensive data from Ohio animal shelters showed a 17% decrease in
the number of dogs entering shelters and a 39% decrease in the number of dogs
euthanized between 1996 and 2004.11 The American Society for the Prevention of
Cruelty to Animals estimates that 3.3 million dogs entered shelters in 2017, with
euthanasia of about 670,000 dogs, but sampling methodology is not described.12
Additional challenges for shelter populations
Shelter animal population estimates are especially nebulous due to lack of
consensus as to what constitutes an “animal shelter”. Organizations with a mission to
rehome unowned animals range from brick-and-mortar physical locations, operated
privately or through municipal funding, to independent foster or breed-rescue groups
which operate solely out of private homes and may span several states. For our purposes,
a shelter is defined as a physical facility which houses dogs that are available for public
adoption. This encompasses municipal facilities and private shelters, but excludes animal
sanctuaries and foster-only programs.
It can be difficult to locate shelters and determine if they meet inclusion criteria,
even when clearly defined. At present, animal shelter registration is required in about half
3

of US states, usually through the state department of agriculture, public health division,
or veterinary board. States that do maintain registries differ in criteria which require
facilities to be registered including population size, private versus municipal/county run
facilities, and regulated inspection, making comparisons between states difficult. Past
efforts to consolidate such lists have not been sustained.13
When registry is not required within a state, shelters must be identified through a
laborious process involving internet, social media, and personal contact. Shelters that do
not have a website, social media profile, or other online presence are likely to be missed,
and shelter information from all sources is frequently outdated. Identified shelters and
associated animal groups often require direct communication to determine if shelter
inclusion criteria apply due to ambiguous descriptions of some foster-only groups,
support groups for local shelters that are not separate entities, and changes in shelter
name, address, or contact information.14 Failure to identify all shelters may underestimate
shelter animal populations. Alternately, failure to exclude organizations that do not meet
shelter criteria may result in an overestimation. Care must be taken when extrapolating
population data from known shelters and applying this “average” intake to the expected
number of shelters, as readily available data may over-represent well-resourced, highpresence facilities with large populations.
The constant movement of animals into, between, and out of shelters can make it
difficult to accurately quantify the shelter population. Most shelters track animal intake
(including strays, owner relinquishments, or transfers) and outcome (including adoption,
return to owner, transport, or euthanasia). Population estimates based on intake numbers
may be inflated due to duplicate counting of animals. For example, free-ranging owned
4

animals may enter a shelter numerous times through animal control, with each visit
counted as a separate intake unless a unique identifier such as a microchip is available.
Shelters may also exchange animals with partner shelters or foster groups, resulting in
animals recorded as an intake at both the destination shelter and source shelter.
There is very limited information available on the shelter animal population of
Mississippi. Indeed, with a lack of mandatory registration in the state, there is not even a
good estimation of the number of animal shelters and associated groups operating within
the state. The Mississippi Board of Animal Health maintains a limited list of shelters that
have registered for supplemental state funding received through specialty automobile
license plate fees, and the Humane Society of the United States has compiled an
incomplete list of animal organizations in the state. Based on personal communication
with animal shelter directors across Mississippi, annual intake at most animal shelters has
steadily increased over the past 5-10 years, while euthanasia rates have decreased. This
indicates that more animals are exiting shelters through local adoptions or transport
programs.
Shelter dog epidemiology
Dogs may enter a shelter through several routes including owner surrender, return
to the shelter following unsuccessful adoption, stray capture by animal control or
members of the public, or transfer/transport programs. Each of these intake sources has
unique or overlapping risk factors which may contribute to unequal rates of disease
exposure between these subsets of the shelter dog population and from the owned dog
population. Consideration of these risk factors is important when relevant to the
transmission or pathophysiology of a specific disease.
5

It is reasonable to assume dogs entering shelters as owner surrenders may be
similar to the owned pet population. However, there may be characteristics of
relinquished dogs and their homes that contribute to both increased risk for
relinquishment and risk for disease exposure. Salman et al. found that top reasons for dog
relinquishment to shelters included pet illness, cost of pet maintenance, inadequate
facilities, and too many animals in the household/lack of homes for litter mates.15 Thus,
relinquished dogs may be at increased risk for clinical disease, lack routine veterinary
preventive care, have increased exposure to overcrowding or substandard housing
conditions, and be more likely to be reproductively intact compared to the general owned
pet population.
Stray dogs have often been targeted as high-risk populations for disease due to
lack of preventive care and increased environmental exposure to wildlife and vectors.16-17
Urban and rural stray dogs have differing exposures to domestic and wild animal
populations, however, contact is likely much higher than in corresponding owned
populations. Substantial geographic differences in disease seroprevalence may occur
depending on suitable disease vector and host population densities, climate, and
opportunities for transmission. Stray dogs are more likely to be reproductively intact,
range across large territories, and scavenge for food, increasing risk for diseases
transmitted through direct or oral contact.18 Inadequate nutrition and parasitism may
decrease immunity and make stray dogs more susceptible to clinical and subclinical
disease.
Finally, dogs entering shelters through transport or transfer programs may serve
as unique populations in terms of disease prevalence. Transport of shelter dogs occurs
6

both intrastate, between partner shelters, and interstate, from overpopulated regions with
historically high euthanasia rates to regions where shelter dogs are in high demand.
Diseases which occur with regional specificity or with varying prevalence by region may
be transported along with infected individuals. Low index of clinical suspicion for nonendemic disease may result in failure to diagnose cases and may lead to disease
dissemination within the dog population or to other susceptible species, including people.
Such translocation of disease has been reported following mass movement of animals
following a natural disaster, but may also frequently occur with routine movement.19
Most shelter dogs are visually screened for signs of disease and receive routine
diagnostics (e.g. fecal parasite exam and heartworm test), but rarely have a
comprehensive medical work-up performed prior to transport.
Movement of shelter dogs is particularly common out of the southeastern United
States. Although total numbers of transported dogs have not been reported, a small
program operated through the College of Veterinary Medicine at Mississippi State
University has moved over 4,600 dogs out of state since it was founded in 2007. It is
estimated that an additional 60 such programs exist within the state of Mississippi
(personal communication). This yields a conservative estimate of over 25,000 dogs
transported annually out of Mississippi alone. Dogs in the southeastern United States may
have greater risk for disease due to year-round presence of arthropod vectors and
socioeconomic factors affecting animal perception and care. Increased prevalence of
intestinal parasitism and vector-borne disease such as canine heartworm and West Nile
Virus have been documented.17, 20-21 Reports have also found the highest prevalence of
canine brucellosis in the Southeast and have linked introduction of disease into new dog
7

populations with interstate movement of dogs.22-23 Shelter dogs may thus serve as a route
of dissemination for many diseases.
Prevalence of disease in shelter dogs
Studies have documented dramatically different rates of disease seroprevalence
between owned and stray dogs. Reasons for these differences likely include a
combination of the previously noted risk factors, such as differences in environment,
behavior, and food sources, however, they may also reflect intrinsic dog characteristics
such as the age, sex, and breed distribution of shelter dogs compared to the owned dog
population. For example, Little et al. found that shelter dogs were almost 10 times more
likely to be infected with hookworms compared to owned dogs in the Southeast.20
Authors attribute much of this difference to the age distribution in sampled dogs, with
dogs over 3 years of age comprising 50% and 16% of the owned and stray dog
populations, respectively. Hookworms rarely parasitize adult dogs, so the critical risk
factor for being infected is likely the differing age distribution between owned and shelter
dogs rather than anthelmintic treatment. A clear understanding of shelter dog
demographics is therefore essential for correct risk interpretation.
Differing demographics between owned and shelter dog populations are also
important for diseases with known breed predilections. For example, Macintire et al.
demonstrated that Babesia gibsoni is found predominately in American Pit Bull Terriers
in the southeastern United States.24 This breed is overrepresented in animal shelters in the
Southeast due to popularity as pets, overbreeding, and breed-specific legislation or stigma
which may limit adoptability. Disease rates in shelter dogs would be expected to be
correspondingly high, even though there is no evidence that classification as a shelter dog
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is itself a risk factor for babesiosis. Lim et al. also noted a breed bias when evaluating
vector-borne diseases between hunting and shelter dogs. Shelter dogs were not
seropositive for tick-borne diseases, however, the sampled shelter was in a heavily
urbanized area with over 80% of the shelter dog population composed of toy-type breeds
(including Maltese, Shih Tzu, Yorkshire terriers, and poodles) typically kept in homes
and not exposed to vectors through outdoor recreation.25
Sex, including neutered status, is often evaluated as a risk factor for disease.
However, this seemingly simple classification can be difficult to apply to shelter dogs,
especially in seroprevalence studies. Many animal shelters actively spay and neuter intact
dogs that enter the shelter, making it very difficult to determine if disease exposure
occurred before or after castration. For example, Brown et al. found that female dogs
were more likely to be seropositive for Brucella canis than male dogs, but did not
differentiate sexually intact from non-intact dogs.26 Reproductive status is an important
risk factor, with transmission primarily occurring through whelping or breeding, and
because zoonotic risk is believed to be much greater in intact dogs. A cross-sectional
study which evaluates dog characteristics and sample results at a single time can be
misleading if disease exposure and seroconversion occurred prior to castration, or if
female reproductive status is unknown; such a study would likely fail to identify being
reproductively intact as a risk factor, even though it represents the most important route
of exposure.
For other diseases, extrinsic factors more readily explain disease occurrence. A
study of Lyme disease in Spain documented the highest seroprevalence among stray dogs
and those used for hunting or herding compared to pet or watch dogs. Although breed
9

differences are expected within these groups, study authors attributed findings to low use
of acaracides in dog groups with high exposure to ticks.27 Similarly, Trypanosoma cruzi
titers were increased in both rurally owned dogs and stray dogs which had exposure to
vector and mammalian hosts, and seroprevalence of West Nile Virus in strays was almost
double that of family dogs.17,28 In still other cases, such as with fecal shedding of
Salmonella and Campylobacter spp., an interplay of extrinsic and intrinsic factors may
contribute to higher positivity rates in shelter dogs compared to owned dogs.29 Stray dogs
may have greater environmental exposure leading to infection, or stray dogs may be more
susceptible to colonization and shedding due to immunosuppression from the effects of
poor nutrition, stress, and concurrent disease.
Conclusions
The shelter dog population has unique risk factors that may contribute to differing
prevalence of disease from the owned dog population. Knowledge of disease prevalence
in this population is therefore essential for correct application and interpretation of
diagnostic tests and risk assessment in animal shelters. In order to determine disease
prevalence, sampling must be performed in such a way that bias is minimized, and with
sufficient power to allow for assessment of intrinsic and extrinsic risk factors. This
requires a representative sampling frame, which is currently unknown for Mississippi.
The author proposes a study combining methodology from several regional
shelter surveys to determine the number and distribution of animal shelters and shelter
dogs in the state. Components include shelter-finding, verification of inclusion criteria
and direct data collection, and data analysis including standardization to minimize
recognized sources of bias.11,30-32 A census of Mississippi animal shelters will provide a
10

baseline for future trend monitoring of the shelter dog population within the state and
serve as the sampling frame for seroprevalence research.
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Brucellosis: do shelter dogs pose a significant zoonotic risk?
Introduction
Of the recognized zoonotic diseases, perhaps none is so intimately linked to
human history as brucellosis. It has been the proposed etiology for vertebral lesions on an
early hominin skeleton from South Africa dating back 2.5 million years ago, making it
the earliest reported infectious disease of humans, and has been hypothesized as the 5th
Biblical plague of Egypt.33-34 Micrococcus melitensis was first isolated from British
troops as the causative agent of Malta fever in 1887 by Dr. David Bruce, for whom the
genus would eventually be named. Just a decade later, L. F. Benhard Bang identified a
similar bacterium in cattle which would earn his moniker and become one of the most
notorious diseases of veterinary medicine. The zoonotic link between human and animal
health was confirmed in 1905 with the isolation of the bacteria from the milk of healthy
goats, while research by Alice Evans was pivotal in the development and widespread
acceptance of milk pasteurization guidelines in the United States.35
Despite centuries of coexistence and over 100 years of study, brucellosis remains
a significant global risk to human and animal health. The World Health Organization has
gone so far as to state, “We regard brucellosis as the world’s most widespread of all
zoonoses and apart from its toll on people, it has an enormous impact on the animal
industry”.36 Though uncommon in most of the developed world, there are over half a
million human cases annually which result in chronic, debilitating illness and require
prolonged, multi-drug antibiotic regimens.34 Even more alarming, this number likely falls
far short of the truth, as the disease is insidious, with non-specific clinical signs, and
occurs most frequently in low income regions where risk for under-diagnosis is high.37
12

Mortality rates are low, but relapse and bacterial persistence for months to years after
resolution of signs is common.38
Taxonomy and Global Occurrence
Brucellosis is caused by gram negative, non-motile, non-spore forming bacteria in
the family Brucellaceae. Following oral, aerosol, or contact exposure, the bacteria invade
dendritic cells and take up intracellular residence.39 From this immunologically protected
location, the bacteria interfere with normal host cell functions including apoptosis. Thus
robbed of the means to fight the bacteria directly or instigate programmed death of
infected cells, hosts harbor the bacteria with high numbers present in tissues or shed in
bodily fluids. In addition to horizontal transmission, the bacteria can also be vertically
transmitted, with cellular targets including placenta, sperm, and the mammary gland.37
Although brucellosis has a significant impact on human health, it is primarily
maintained within a small number of specific animal host species. Prior to 1985, six
classical Brucella species had been identified: Brucella melitensis in sheep and goats, B.
abortus in cattle, B. suis in swine, B. neotomae in rodents, B. canis in dogs, and B. ovis in
sheep.37 This static phylogeny has recently been shaken with the addition of four new
species since 2007: B. ceti in whales and dolphins, B. pinnipedialis in seals and sea lions,
B. microti from the common vole, and B. inopinata isolated from a human. There are
additional potential species awaiting classification, including a strain isolated from
Australian rats and one identified as the causative agent of abortion in non-human
primates.40
Not only are new Brucella spp. being identified, there is also documentation of
the classical species in new hosts. Cattle serve as the natural hosts for B. abortus, but they
13

can also be infected with and shed B. melitensis as well as B. suis in milk.36 Wildlife is
also at risk. Freshwater river fish have become infected by feeding on contaminated meat,
and the elk and bison around Yellowstone National Park are an infamous lingering source
of B. abortus in the United States.40 Brucella suis has the widest host range, with
documented infections in domestic dogs, bison, elk, fox, hare, African buffalo, reindeer,
caribou, chamois, and ibex. The importance of these new host species is largely
unknown; in some instances, such as B. suis in cattle, the disease appears to be relatively
self-limiting, while in other cases these species serve as unexpected maintenance hosts.36
Brucellosis is considered a re-emerging zoonosis, with incidence of disease in
human and animal populations affected by social, economic, political, and surveillance
factors.35 Global incidence is unknown, with reports in endemic areas ranging from less
than 0.01 to more than 200 cases per 100,000 people.36 In the United States, brucellosis
cases have dropped from a peak of 6,321 in 1947 to about 100 per year since 1998,
largely attributed to widespread milk pasteurization and a national eradication program.35
Even within the United States, there has been a dramatic shift in brucellosis ecology.
Brucella abortus cases were most common prior to the 1960s, followed by a
predominance of B. suis in slaughterhouse workers in the 1970s. Today, brucellosis in the
United States is mainly an imported disease, contracted while traveling abroad or through
contaminated cheese and dairy products originating in Mexico and linked to the higher
incidence seen in Hispanic populations in Texas and California.34 Occasional human
cases also occur through contact with feral swine or exposure to infected domestic dogs.
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Diagnostic Challenges
Definitive diagnosis of brucellosis poses several challenges. Infected people and
animals are often asymptomatic or have vague clinical signs, including undulant fever
and arthralgia, which may go undiagnosed in non-endemic regions due to low physician
awareness of the disease.41 Laboratory tests are complicated by the close genetic
similarity among the Brucella spp. and cross reaction with Yersinia enterocolitica 0:9 and
other gram negative bacteria which result in false positives on common serological
screening tests.36 Serological tests may also result in false negatives due to prozoning, or
antibody excess, where insufficient antigen is present in an assay to create antibody
cross-linking and visible agglutination. Many brucella tests have been developed and are
used in various combinations due to the inherit limitations of each.
Culture of Brucella spp. from the blood or tissues has been traditionally
considered the gold standard, with some authors considering it “essential” for diagnosis.42
Although infected animals have a prolonged bacteremia, intermittent periods of
abacteremia may occur and result in false negatives.43 Additionally, Brucella spp. are
fastidious and can be difficult to culture, with low numbers of bacteria typically found in
the blood.22 In one study, culture-positive and culture-negative dogs all demonstrated
histopathological lesions consistent with brucellosis, and dogs were equally likely to be
positive by polymerase chain reaction (PCR) whether they were culture positive or
negative.44 Clearly, culture does not identify every infected individual, and is dependent
on laboratory experience with the agent and quality of the diagnostic sample. This creates
a quandry for assessing performance of other diagnostic tests when culture alone is used
to determine “true” infection status.
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Tests to detect Brucella antigen or DNA, including indirect fluorescent antibody
tests and PCR assays, have been developed but are not readily available or well
validated.42 Individual laboratories have developed multiplex PCRs including the AMOS
and Bruce-ladder PCR which can identify the 4 smooth species (B. melitensis, B. abortus,
B. suis, and B. neotomae) and 6 classical species (including B. canis and B. ovis)
respectively, following successful culture. More advanced analyses, such as variable
number of tandem repeats, may be useful in epidemiologic trace-backs, differentiating
relapse from reinfection, and to help identify vaccine candidates.37 However, to date,
these opportunities have not been realized.
Serology is most commonly used for initial screening for brucellosis. Serological
tests targeting the O-antigen of the lipopolysaccharide (LPS) molecule do not
differentiate among the naturally occurring smooth colony forming species, however,
there is not cross reaction with rough colony forming species (B. canis and B. ovis) that
lack LPS on the cell surface.45 This may result in failure to diagnose human cases of B.
canis, for which there is no routine screening test. Most tests used to screen livestock for
brucellosis use B. abortus antigen, while tests used to detect canine brucellosis use either
B. ovis or a non-mucoid variant of B. canis which produces less cross-reaction than
traditional B. canis antigen tests.42,45
Several serological tests are approved for testing of livestock prior to international
trade including the enzyme-linked immunosorbent assay (ELISA), fluorescence
polarization assay (FPA), rose-bengal test (RBT), buffered acidified plate antigen
(BAPA) test, and complement fixation test (CFT).46 A variety of tests have also been
used to detect disease in dogs, with the tube agglutination test (TAT) being widely used
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in the 1970’s after the identification of B. canis.42 Tests often incorporate 2mercaptoethanol (2-ME) to reduce disulfide bridges between immunoglobulin M (IgM)
antibodies and limit non-specific agglutination with other gram negative bacteria. More
specific IgG antibodies have fewer disulfide bridges and agglutinate even in the presence
of 2-ME, improving test specificity and reducing false positive tests. False negative tests
can occur in the first 4-6 weeks of an infection, prior to the development of a strong IgG
response.45
Tube agglutination tests are performed via serial dilution and provide semiquantitative measures of antibody present within a sample. Interpretation of a test as
positive or negative is dependent on the cutpoint assigned. Samples with agglutination at
a dilution ≥1:200 are usually considered positive for brucellosis, while those without
agglutination at 1:50 are negative; samples with complete or incomplete agglutination
between these values are often termed suspect with additional testing recommended.42
This interpretation is not unanimous, making it difficult to compare studies using
different cutpoints to determine seroprevalence. One noteworthy case found an overall B.
canis seroprevalence of 67.8% in people with average exposure to dogs. The researchers
considered samples positive if agglutination occurred at a dilution of 1:12,47 with harsh
criticism that this cutpoint greatly overestimated human exposure.43 Currently, TATs or
similar semi-quantitative ELISAs may be most useful as a way to monitor therapeutic
response in treated animals.42,48
A commericial rapid slide agglutination test (RSAT) has mostly replaced the
more laborious TAT for initial testing of dogs for canine brucellosis. Shortly after its
development, the test earned a reputation for producing false positivies in dogs
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apparently uninfected by blood culture and other serological tests, but was touted for lack
of false negatives.43 The test has retained this reputation, despite more recent evidence
that the test had modest sensitivity and specificity of 70.6% and 83.3%, respectively,
compared against a “true” disease status determined by a combination of clinical disease,
culture, and PCR of blood and genital samples.49 These values are reported for test
performance on the commericial product, with the claim that it “immediately separates
negative dogs from those potentially infected”.50 This statement is in direct contradiction
to study authors who note that “the occurrence of false-negative results observed in this
study indicate that these tests should be carefully employed as screening tests for canine
brucellosis diagnosis, because a significant proportion of the infected dogs were not
detected”.49
Additionally, the commercial test kit does not report diagnostic performance with
the addition of 2-ME following a positive test. Keid et al. found a sensitivity and
specificity of 31.8% and 100%, respectively, when samples were tested with the 2MERSAT, however, no study has reported overall test performance when conducted in series
as per test instructions.49 Based on the work of Keid et al., the commercial RSAT,
performed with follow-up addition of 2-ME to positive samples, is most useful to confirm
that a dog is infected, but serves poorly as a screening test due to low diagnostic
sensitivity. This stark opposition to earlier findings has unfortunately been overlooked in
current diagnostic testing recommendations from organizations ranging from the
American Kennel Club to public health departments. A better understanding of the RSAT
test performance compared to “true” disease status is needed, along with a paradigm shift
in veterinary diagnosis of canine brucellosis.
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Brucellosis epidemiology in dogs
Dogs are the natural hosts for B. canis, but can also be infected with B. suis, B.
melitensis, and B. abortus through contact with domestic or wild animals.51-55
Transmission of all Brucella spp. occurs predominately through breeding and parturition,
with the highest loads of bacteria shed in placenta and birthing fluids during abortion.43
Infection can also occur via consumption of contaminated milk or meat, or contact with
blood, urine, and saliva.56 Infected dogs may remain bacteremic for at least 2 years.43
Infected dogs are often asymptomatic or show classic signs of reproductive failure
including abortion and infertility. Male dogs may develop orchitis or epididymitis, with
localization of bacteria within these sites leading to abnormal sperm or
aspermatogenesis.43 Infected female dogs may fail to carry a litter to term, give birth to
healthy puppies, or transmit the infection vertically or horizontally through reproductive
materials.22 Intact bitches also appear to be at risk for recrudescence during estrus with a
transient increase in antibodies levels measured in subsequent heat cycles.57 Other
relatively common clinical presentations include endophthalmitis and uveitis, or
discospondylitis with associated neck or back pain.22,48,58 Hematological parameters in
infected dogs are usually normal or show only leukocytosis.48
Treatment of infected dogs is difficult and carries risk for recrudescence, as in
human patients. Tetracyclines show good in vivo efficacy against B. canis, and have been
used alone or in combination therapy.58-61 Other common therapeutic regimens have used
aminoglycosides, fluoroquinolones, and rifampin in various combinations and with
variable success.57,62 Most dogs show clinical improvement within the first two weeks of
therapy and are abacteremic within 4 weeks of starting treatment.48,58
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Serological tests may remain positive for long periods of time following treatment
and resolution of clinical signs. Ledbetter et al. found a median time to seronegativity of
96 weeks with a range of 36 to 112 weeks in three dogs with unilateral uveitis.48 Wanke
et al. reported that all treated dogs in a breeding kennel were serologically negative 14
months after initial treatment, however, female dogs received additional antibotitic
courses during subsequent estrus cycles.57 Use of serology to monitor response to
treatment and time to seronegativity is often recommended, however, the relationship
between antibody levels and treatment success is poorly understood and guidelines are
not well established.
Brucella canis in dogs in North America
Brucella canis was first described and identified in a population of breeding
beagles in the late 1960’s, followed shortly after by the first human case acquired from an
infected dog.63-66 Research during the following decade provided insight into
pathogenesis, diagnosis, and treatment, however, B. canis was classified as a low
zoonotic risk with clinical importance primarily limited to a causative agent of abortion
and infertility in breeding kennels.22 Positive cases are identified most often through
outbreaks of disease in breeding kennels or with apparent clinical signs in companion
animals.22-23
Serological studies measuring disease occurrence in asymptomatic dogs in North
America have sporadically been reported (Table 1.1). Comparisons of prevalence
between studies is difficult due to differences in populations sampled and diagnostic
testing procedures performed, however, stray dogs have consistently higher
seroprevalence compared to owned animals. In most studies, samples were collected
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using convenience methods and may poorly represent the target population. Intrinsic risk
factors for disease such as breed, sex, and age have rarely been reported. Additionally,
the majority of the studies were performed shortly after the identification of B. canis,
with very little recent information available on seroprevalence in the United States.
At least 30 cases of B. canis in humans have been attributed to contact with
infected dogs globally, including an outbreak of 6 people who all developed disease from
a single pet dog and affected litter.67 A human case in Jackson, Mississippi, was
diagnosed in 2016 following contact with a stray dog that aborted a litter of puppies
while in a foster home (personal communication). Canine cases were subsequently made
reportable to the Mississippi Board of Animal Health due to the zoonotic risk posed, and
there is current interest in tracking surveillance information including clinical case
information to assess canine risk factors.68
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Table 1.1
Location

Prevalence of B. canis in North America
Population

Diagnostic

Prevalence

Source

3.65% (10/274)

Hoff and Nichols,

Test
FL

274 shelter dogs from 21

ME-TAT

197469

facilities in 16 counties
TN

121 stray dogs;

ME-TAT

107 owned dogs
TN
GA

Stray: 6.6% (8/121)

Fredrickson and

Owned: 1.9% (2/107)

Barton, 197470

235 stray dogs;

Titers (test

Stray: 9.4% (22/235)

Lovejoy et al.,

67 owned dogs

unspecified)

Owned: 0%

197671

100 stray dogs from an

RSAT

Stray: 9% (9/100)

Brown et al.,

animal shelter; 100 pets

followed by

Pet: 1% (1/100)

197626
Galphin, 197772

ME-TAT
147 owned dogs and 13

RSAT

Stray: 7.6% (1/13)

stray dogs sampled from

followed by

Owned: 0%

an air force base

ME-TAT

Quebec,

341 randomly sampled

RSAT

RSAT: 20.2% (69/341)

Higgins et al.,

Canada

dogs submitted to

followed by

ME-TAT: 1.8% (6/341)

197973

diagnostic laboratories

ME-TAT

MS

for unrelated testing
WI and

2,572 shelter dogs from

RSAT, ME-

RSAT: 6.7%

Boebel et al.,

IL

eight counties

TAT, blood

ME-TAT: 1.5%

197974

culture

Culture: 0.2%

ME-TAT

Urban: 8.6% (43/499)

Thiermann,

Suburban: 5.7% (7/123)

198075

MI

499 urban stray dogs;
123 suburban stray dogs

Ontario,

555 kennel clubs/

RSAT

RSAT: 5% (100/2000)

Bosu and

Canada

breeders; 1,4445

followed by

TAT: 31 suspicious and

Prescott, 198076

laboratory samples

ME-TAT and

1 positive

unrelated to brucellosis

AGID

AGID: 6/100

testing
OH

200 stray dogs at a single

Overall: 0.3%
ME-TAT

shelter; 470 owned dogs

Stray: 1.5%

Pue, 198377

Owned: 0.4%

from veterinary clinics
WI

510 samples submitted

RSAT

’03-’04: 4.6% (8/174)

Brower et al.,

to diagnostic lab for

followed by

’05: 26.8% (85/317)

200723

testing

ME-RSAT

Studies are listed chronologically by publication date.
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Brucella suis in dogs
Brucella suis has the broadest host range among the known Brucella spp. (Table
1.2), although domestic and feral swine are the maintenance hosts for most biovars. The
disease has been eradicated from domestic swine in the United States, but feral swine
remain reservoirs for disease. Swine were first introduced into the United States during
the European settlement in the 1400’s as a meat source. Subsequently, feral swine have
established populations through intentional release of both the Eurasian wild boar and
domestic swine for hunting, by escaping from confinement operations or game reserves,
and through abandonment.78 Currently, feral swine are present in at least 39 states with an
estimated population over 5 million.79 Feral swine carry over 30 bacterial or viral
diseases and 37 parasites, including 8 zoonotic diseases, in the United States, and remain
as reservoirs for brucellosis, pseudorabies, and bovine tuberculosis, placing national
disease-free status at risk.79-80
Table 1.2

B. suis biovar hosts and distribution

BIOVAR HOSTS

GLOBAL DISTRIBUTION

1

Domestic and feral swine

Majority of feral swine cases in the US

2

Domestic and feral swine,

Low human pathogenicity; results in

European wild hare population

pathognomonic intramuscular abscesses in
wild hares in Europe

3

Domestic and feral swine

Present in feral swine in the corn belt of the
US and Hawaii

4

Reindeer and caribou;

Zoonotic risk through consumption of raw

spill-over to rodents, foxes,

milk, meat, and bone marrow in the Arctic

wolves, and sled dogs
5

Rodents

Limited to Australia, Kenya, and Siberia

Information summarized from Aparicio.80
23

The prevalence of B. suis appears to be increasing in the United States, along with
feral swine range. A 2010-2012 study found at least one serologically positive animal in
7 of 8 states surveyed, and demonstrated that under-reporting may be a serious concern as
only 52% of culture positive animals tested positive by serology at a nationally certified
brucellosis laboratory.82 Feral swine have been implicated in the introduction of
brucellosis to three domestic swine herds and one cattle herd, and have been associated
with transmission of brucellosis to several feral swine hunters through dressing or
consumption of game.55,79,83
Brucella suis has rarely been reported in domestic dogs, with the exception of
biovar 4 in the Arctic, however, low apparent prevalence may be a result of failure to test
for the disease.55 Brucella suis was identified in a dog as early as 1931,84 but the
majority of canine testing is targeted at B. canis which does not cross-react with B. suis.
Early experimental infection of beagle dogs with B. suis resulted in asymptomatic
infection, but bacteria were isolated from the spleen, lymph node, kidney, and salivary
gland, with hypothesized potential for human infection from infected canine urine or
saliva.56 Natural infection with B. suis was identified as the causative agent of a dog
presenting for hind limb lameness,51 and a recent study in Georgia identified 9 of 674
dogs serologically positive for B. suis.52 Bacteria were isolated from samples submitted
on two dogs in the latter study, and all serologically positive dogs were used for feral
swine hunting. Transmission routes are unknown, but ingestion of carcass or birthing
materials seem likely.55
Mississippi has both a robust feral swine population carrying highly pathogenic
biovars of B. suis85 and a large free-ranging dog population which may come into contact
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with wildlife. Although dogs used for feral swine hunting are at greatest risk for
contracting disease, the zoonotic risk posed by dogs might be highest for stray dogs
entering a shelter which may then be adopted into a home and brought into close contact
with family members. The zoonotic potential of B. suis in dogs is unknown; however, B.
suis in natural hosts carries substantial zoonotic risk, resulting in potential transmission of
a debilitating disease that is challenging to diagnose and treat.55 Knowledge of the
seroprevalence of B. suis in the shelter dog population may help quantify this risk.
Conclusions
Brucellosis in dogs has received little attention except as a cause for reproductive
failure in breeding populations. Almost all reports of disease occurrence in dog
populations were performed in the first two decades following B. canis identification,
with little recent information available on the current epidemiology in domestic dogs in
North America. Serosurveys of several dog populations, including breeding dogs, pet
dogs, and stray or shelter dogs have failed to identify intrinsic dog risk factors such as sex
or breed, however, there is evidence that stray dogs have considerably greater likelihood
for being seropositive compared to owned dogs. A serosurvey of a single Mississippi
location identified a positive stray dog,72 while surrounding southeastern states have
found a seroprevalence between 3-9% in shelter dogs (Table 1.1).
The discovery of domestic dogs in the Southeast infected with B. canis and recent
human brucellosis cases contracted from dogs continues to provide evidence of zoonotic
potential, despite relatively rare documented transmission to people. Shelter dogs may
serve as an important high-risk population, with dogs frequently entering shelters as
intact, free-roaming strays with increased wildlife and dog-to-dog contact. Apparently
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healthy dogs infected with brucellosis may pose a local risk for human and dog
populations, as well as a route for disease dissemination through interstate shelter animal
transport programs which relocate animals from overpopulated shelters to regions of the
country where shelter dog availability is low. Prevalence data is necessary to assess the
public health risk posed by brucellosis and for correct application and interpretation of
diagnostic tests. Effective control of canine brucellosis will require improved
surveillance, along with education of the general public and veterinary practitioners on
this difficult to diagnose disease.
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American Trypanosomiasis: can shelter dogs serve as sentinels to evaluate human
risk?
Impact on Human Health
Chagas’ Disease
Trypanosoma cruzi is a protozoan parasite and the causative agent of Chagas’ disease
in people. In the century since its discovery by Carlos Chagas in Brazil,86 Chagas’ disease
has been extensively researched and several large-scale control programs have been
implemented. Despite these efforts, the disease still contributes the greatest burden of
parasitic disease in the Americas, accounting for 40% of disability adjusted life-years lost
to all parasitic and vector-borne diseases.87 Although much less common than in South
America, in the United States over 300,000 people are believed to be infected. The most
common manifestation of disease is cardiomyopathy, affecting 30,000 to 45,000
Americans each year. Additionally, an estimated 63 to 315 congenital cases occur
annually in the United States, contributing to the high health care costs of the disease.88
Humans contract Chagas’ disease by one of three primary routes: stercorarian (fecal
origin), congenital, or oral. Members of the Reduviidae family, commonly known as
kissing bugs or cone-nosed bugs, are biological vectors and carry the parasite in their gut.
Infection occurs when these nocturnal insects defecate while feeding on the blood of
sleeping people. Parasites in feces enter a host through the bite, which is often located
near the eyes or mouth, or across mucous membranes, and may result in the characteristic
unilateral palpebral swelling known as the Romaña sign.89 Congenital transmission may
occur in up to 10% of infected mothers and represents an important route in regions
where the vector is not present.90 Oral transmission has been reported following ingestion
of infected bugs or products contaminated by bugs or their feces; this route is currently
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limited to the Amazon region and certain high-risk foods and drinks.91 In the United
States, most new cases result from congenital transmission or through contaminated
donor products such as blood and solid organs. Competent vectors are widely present in
the southern half of the United States and may serve as an important risk for stercorarian
transmission, however, to date, autochthonous cases are rare.92-93
The majority of people infected with T. cruzi do not show clinical signs, while
approximately 20-30% develop severe cardiac disease or gastrointestinal illness. Disease
pathogenesis and reasons for variability in response to infection is poorly understood, but
may reflect differences in host immune response, virulence of the infective T. cruzi strain,
or superinfection of an individual with multiple T. cruzi strains.94 Acute disease occurs 1
to 2 weeks after vector-borne transmission and is characterized by presence of
trypomastigotes in the blood. Most cases are asymptomatic or present with mild fever,
malaise, hepatosplenomegaly, and lymphocytosis. Swelling at the infection site
(chagoma) or eyelid edema (Romaña sign) is uncommon but diagnostic. Serious
infections occasionally result in meningoencephalitis or myocarditis which may be life
threatening.89 Diagnosis during the acute phase is typically made by visualization of the
parasite in blood smears, culture, or positive polymerase chain reaction (PCR).94
Resolution of the acute phase occurs with clearance of parasitemia in 4 to 8 weeks.
People then enter the indeterminate phase, which is an asymptomatic period of infection
with intracellular amastigotes potentially lasting for life. Diagnosis is made via positive
serology with corresponding lack of evidence of cardiac or gastrointestinal disease.94
Progression to the determinate phase occurs in some individuals, with development of
electrocardiogram (ECG) abnormalities and progressive cardiomyopathy or development
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of gastrointestinal Chagas’ disease characterized by motility disorders and subsequent
dilation of the esophagus, colon, or both. Chagas’ cardiomyopathy results in the greatest
burden of disease with severe cardiac dysfunction and risk for sudden death from heart
failure or thromboembolism.95
Treatment
Treatment options for Chagas’ disease are limited. Nifurtimox and benznidazole are
effective in treating T. cruzi infections, however, neither are readily available and dosedependent side effects complicate use, especially in asymptomatic cases. Benznidazole
has been approved for use in children 2 to 12 years of age but is currently only available
through the Centers for Disease Control and Prevention (CDC). Side effects are less
severe than with use of nifurtimox, especially in children, but may include allergic
dermatitis, reversible peripheral neuropathy, insomnia, anorexia, and bone marrow
suppression.96 Nifurtimox is not approved for treatment of T. cruzi but can be obtained
under investigational protocols. Gastrointestinal side effects are most common, occurring
in up to 70% of patients. More serious side effects such as paresthesia and
polyneuropathy have been reported.94
Antitrypanosomal drugs are most effective in acute disease and when used early in
congenital infections, reducing both severity and duration of disease. More recently,
treatment has also been recommended in chronic cases, with evidence of conversion to
seronegativity in children 3 to 4 years after treatment.94 Current recommendations also
advise treatment of chronic cases in adults, however, a large randomized placebo-control
trial failed to detect a reduction in the progression of cardiac disease in individuals
receiving treatment.97 Treatment of Chagas’ cardiomyopathy and gastrointestinal Chagas’
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disease does not differ from other causes of heart disease and idiopathic motility
disorders, and guidelines have been established to monitor disease progression from the
indeterminate to determinate stage.94
Disease control and emergence
Four large intergovernmental Chagas’ disease control programs have been
implemented in South America since 1991: the Southern Cone, Central American,
Andean Pact, and Amazonian Initiatives.98 These programs have achieved notable
success in Latin America, with a reduction in annual new cases from 700,000 in 1990 to
41,200 in 2006.99 Methods of vector control and subsequent interruption of transmission
have included insecticide use, improvements to rural housing where the vector kissing
bugs reside, public education, and intensified blood product screening.100 Despite these
positive trends, the global burden of Chagas’ disease is estimated to exceed US$600
million in annual health care costs and 800,000 disability-adjusted life-years.101
Increasingly, Chagas’ disease is recognized as an emerging disease in many parts of
the world, primarily in the immigrant populations of North America, Europe, Australia,
and Japan. The United States and Canada account for 18.9% of annual global health-care
costs associated with Chagas’ disease, a value which could increase considerably if the
disease becomes endemic in areas where competent vectors are currently located.101 In
the United States, Chagas’ disease remains an important public health risk for congenital
transmission in Latin American immigrate populations, through possible transmission in
donor blood or organs, and due to poor surveillance to detect autochthonous cases.102

30

Epidemiology of American trypanosomiasis
Life cycle and genotypic diversity
Trypanosoma cruzi has a complex life cycle, requiring a reduviid vector (subfamily
Triatomae) and a mammalian host to undergo maturation through all three morphological
forms.103 In the traditional route of transmission, metacyclic trypomastigotes are passed
in the feces of a kissing bug and enter a mammalian host through the bite wound or
exposure to a mucous membrane. The flagellated parasites may infect macrophages or
become intracellular amastigotes which replicate via binary fission and transform back
into trypomastigotes once released into the blood stream.104 Hematogenous spread can
result in disseminated infection, with cardiac and neural cell trophisms. Triatomine bugs
feeding on an infected mammal ingest circulating trypomastigotes, which differentiate
into replicative epimastigotes in the insect midgut. Once in the hindgut, epimastigotes,
characterized by a kinetoplast located anterior to the nucleus, transform into the infective
trypomastigote stage, in which the kinetoplast is located posterior to the nucleus.103
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Figure 1.1

Lifecycle of T. cruzi

Image from the Centers for Disease Control and Prevention.102
The diversity of T. cruzi was recognized shortly after its discovery, contributing to
the variability of clinical signs, severity, and occurrence of Chagas’ disease. Phenotypic
differences have been substantiated by molecular typing, leading to several different
classification schemes for different strains of the organism.105 Early work using multilocus enzyme electrophoresis (MLEE) identified two distinct strain-groups,106 which
have subsequently been split into six discrete typing units (DTUs) based on 24Sα rRNA
and mini-exon gene analysis.107 Arguments have been made for the speciation of strains
based on genetic variation and niche specificity, however, to date, formal reclassification
has not occurred.105
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Genotypes of T. cruzi demonstrate differences in epidemiology, including
traditional host and vector species (Table 1.3). Two genotypes have been identified in the
United States: T. cruzi I is believed to exist in a sylvatic cycle with Virginia opossums
and has been isolated from triatomine vectors as well as autochthonous human cases,
while T. cruzi IIa occurs in other placental mammals including raccoons, skunks, and
domestic dogs.108 Isolates from the United States show a high degree of genetic variation,
providing evidence that the agent has existed in North American wildlife for a long
period of time.109 Molecular typing may prove useful in tracking disease emergence in
non-endemic countries and in new peridomestic cycles where suitable hosts and vectors
are located.110
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Table 1.3
Genotype
TcI

T. cruzi genotypic features
Niche
Primary:
arboreal,
lowland
topical/semitropical
Secondary: arid
rocky
Arboreal

Sylvatic hosts
Primary: American
opossums,
primates, arboreal
rodents
Secondary:
terrestrial rodents

Sylvatic vectors
Primary:
Rhodnius spp.
Secondary:
Panstrongylus
spp., Triatoma
spp.

Primates,
armadillos, bats,
raccoons (USA)

TcIIb

Rare in sylvatic
cycles

TcIIc

Terrestrial/
burrowing

TcIId

Rare in sylvatic
cycles
Rare in sylvatic
cycles

Atlantic forest
primates,
armadillos
Armadillos,
rodents,
marsupials,
carnivores
Suspect armadillos

Rhodnius spp.,
Panstrongylus
spp., Triatoma
spp.
?

TcIIa

TcIIe

?

Geography
Primary: Southern
USA, Central and
South America
Secondary: North
of Amazon (Central
Brazil, Eastern
Andean foothills)
Northern South
America, USA
Atlantic/Central
Brazil

P. geniculatus,
P. lignarius,
T. rubrovaria

Lowland South
America

?

Southern cone

?

Southern cone

Adapted from Miles et al.110 Question marks indicate unknown host and vector species.
Triatomine Vectors
In addition to genetic variation in T. cruzi, the epidemiology of American
trypanosomiasis is complicated by the diverse feeding habits of reduviid vectors. Over
130 species of triatomine insects have been reported in North and South America,
however, a relatively limited number are associated with occurrence of Chagas’ disease
as a result of their feeding preferences and likelihood to adapt to human dwellings.92 All
triatomine species are hematophagous, and both males and females require blood meals
for maturation. Repeated blood feeding over the life of the insect results in higher
prevalence of T. cruzi infection in adults than nymphal stages, including a greater
likelihood for an insect to be infected with multiple DTUs.111 Triatomine species occur in
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distinct ecological niches, but are nonspecific in the hosts on which they feed. Utilizing a
wide variety of hosts has been associated with both parasite persistence and amplification
or, alternatively, reduction due to a dilution effect depending on the host-vector-agent
interaction.112
Triatomine insects occur throughout the southern half of the United States, with
eleven total reported species. The greatest variety exists in Texas, Arizona, and New
Mexico with at least five species occurring in each state. Two species have the widest
reported ranges: T. protracta occurs across the entire southwest from California to Texas,
while T. sanguisuga occurs in the east from Texas to the Atlantic coast and as far north as
Pennsylvania. Blood meal sources for these insects is highly variable, with at least 24
mammalian species serving as hosts for T. cruzi. Woodrats appear to be the primary
reservoir of T. cruzi in the western United States, whereas high prevalence occurs in
raccoons, opossums, armadillos, and skunks in the eastern United States.92
In a study performed in Texas, five triatomine species contained blood meals from
nine vertebrate hosts, including woodrats, dogs, cats, cows, humans, and raccoons.113
Few vector and wildlife field studies have been performed in the Southeast, potentially
underestimating the range and variety of triatomine bugs present in this region. The
single reported triatomine species in Mississippi, T. sanguisuga, feeds on a broad host
range of sylvatic reservoirs. It has also been found in association with domestic dogs,
chickens, horses, and in or near the homes of human autochthonous Chagas’ disease
cases in Tennessee, Louisiana, and Mississippi.92
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Disease transmission
Complex patterns of T. cruzi infection occur depending on vector and host
populations, transmission routes within sylvatic or domestic cycles, and agent
prevalence.114 Mammalian host species are potentially infected through many routes
involving contact with triatomine insects, their feces, or infectious material from other
mammals. In addition to contamination of bite sites or mucous membranes with feces,
infection can occur following ingestion of infected triatomine insects, consumption of
raw meat or blood from infected mammals, or through contact with infectious material
such as urine or milk.112
Infectivity of T. cruzi appears to depend on host, vector, and agent characteristics.
Infection rates through oral or vector-feeding transmission have been estimated for
raccoons and opossums based on prevalence data,114 but risks associated with specific
host factors, such as age, gender, and health status are poorly understood.111 Triatomine
species vary in defecation behavior following feeding which may contribute to efficacy
as vectors of T. cruzi.115 Additionally, vector behavior, such as ability to adapt to human
residences and attraction to light, may increase exposure of T. cruzi to domestic animal
hosts and humans. Agent factors, including level of parasitemia induced in hosts (i.e.
infectiveness) as well as morbidity or mortality of hosts, may significantly impact disease
epidemiology.111
Oral transmission of T. cruzi is increasingly recognized as a route of disease exposure
for both humans and animals. Several outbreaks in South American have been linked to
consumption of sugar cane juice, acai paste or juice, or other foods products
contaminated by infected triatomines.91 These foods are often made outdoors where
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insect or fecal contamination of the product can occur, especially as triatomine insects are
attracted to light sources which are common around human habitations. Some researchers
have proposed oral transmission as the predominant route of T. cruzi infection in sylvatic
cycles, given the low rates of infection seen with traditional vector-feeding.111 Many
sylvatic species, including raccoons, opossums, and armadillos commonly feed on insects
and oral transmission may contribute to reservoir host maintenance. Raccoons have been
experimentally infected through ingestion of infected triatomine insects, however, the
importance of scavenging or predation of other wildlife is less established. Research has
failed to reproduce disease through these routes in other host species.116
Limited information is available on other routes of T. cruzi transmission. Congenital
transmission in humans has been reported in 1 to 10% of infants from infected mothers
and experimentally demonstrated in rats.92 Naturally occurring congenital transmission
has also been reported in dogs, and recognized as a limitation in the use of dogs as
sentinels for disease during control programs.117-118 Infection through transfusion of T.
cruzi positive blood occurs in 10 to 25% of recipients, with platelet transfusion posing an
apparently higher risk for transmission than packed red cells. Organ transplantation from
infected donors has resulted in at least 19 documented cases.92
Sylvatic disease cycles
The genetic variation of T. cruzi indicates a long period of endemicity in wildlife
from the southern United States and South America.109 Major disease reservoirs include
opossums, armadillos, and rodents, with low mortality seen in sylvatic hosts.112,114
Different T. cruzi genotypes are associated with specific ecological niches and tend to
circulate between a few primary host species with a primary vector species mediating
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transmission.110 Although the dynamics of disease transmission in these cycles is poorly
understood, mathematical models are beginning to provide a framework for
understanding how vector and host populations affect routes and rates of disease
transmission.114 The roles of superinfection, or the reinfection of an already infected host,
and co-infection with multiple genotypes is poorly understood, may by contribute to new
transmission scenarios between atypical vector and host species.111
Sylvatic disease cycles are apparent in the United States, with occasional spillover to humans. In a seroprevalence study of six states, T. cruzi positive wildlife were
identified in every state except California, and up to 68% of raccoons and 52% of
opossums had T. cruzi antibodies.119 California has documented endemic T. cruzi, with an
autochthonous human case occurring in 1982 and reports of focal sylvatic transmission
between Triatoma protracta and ground squirrels.120 In the Southeast, major sylvatic
cycles include raccoons, opossums, and armadillos in association with Triatoma
sanguisuga.121-122 An autochthonous human case in New Orleans, Louisiana, was
attributed to an increase in the local armadillo population and triatomine infestation
following Hurricane Katrina in 2005.123
Domestic disease cycles
Environmental changes such as climate shift and deforestation may lead to
emergence of domestic T. cruzi cycles. Triatomines are generalists and readily feed on
many species, which may include domestic animals and humans when sylvatic host
populations are reduced.111 Dogs, cats, and guinea pigs have all been identified as
amplifying hosts and linked to increased peridomestic disease transmission in South
America. Other domestic animals, including goats, sheep, pigs, and chickens, may serve
38

as blood-meal sources for triatomine bugs and thus increase vector populations, but have
low infection rates and do not significantly contribute to domestic cycles.112 In addition
to availability of suitable hosts, domestic cycles require establishment of vector
populations near human habitations. Adobe and thatch housing, common in South
America, pose a high risk for triatomine infestation and disease transmission.92
American trypanosomiasis in domestic dogs
The role of dogs in domestic transmission cycles
In South America, dogs play a crucial role in domestic T. cruzi transmission. A
study in Colombia identified domestic dogs as potential bridge vectors, bringing T. cruzi
genotypes typically found in sylvatic cycles into domestic environments and resulting in
increased transmission to humans.124 Several studies have identified the presence of
infected dogs to be the greatest risk factor for occurrence of peridomestic
transmission,112-113,125 with human infection rates 4.5 to 4.7 times greater when a
seropositive dog is present in a home.126 Reasons for this association include heavy
vector feeding on dogs, which increases the prevalence of infected dogs and vector
population size, and greater infectiousness of dogs to triatomine insects compared to
humans or other domestic animals.125,127 Not all dogs pose equal risk, however, as dogs
do not display a homogeneous rate of infectiousness. In one study, younger dogs infected
a greater proportion of feeding insects than older dogs, and about 1/3 of dogs were
“super-spreaders”, infecting 40% or more of feeding insects compared to the majority of
dogs that infected less than 10%.127
The importance of dogs in domestic transmission within the United States is
poorly understood. Beard et al. reported a focal domestic transmission cycle between
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domestic dogs and Triatoma gerstaeckeri in southern Texas, identified after three dogs
from a single property died from acute cardiomyopathy.128 Three of four remaining dogs
on site were seropositive for T. cruzi, and 24 of 31 live triatomines of various life stages
collected on-site were infected. Neither person living on-site was seropositive. Additional
work has shown widespread infection in the dog population in Texas, including 8.8%
seroprevalence in shelter dogs from across the state16 and 537 clinical cases diagnosed
between 1993 and 2007.129
At least 10 species of triatomine vectors have been reported in Texas, with
documented occurrence in 97 of 254 counties and three vector species infected with T.
cruzi found in or near houses.130-131 Seroprevalence studies in wildlife have identified
many infected host species and disease is also reported in humans, although
differentiating autochthonous from imported cases can be difficult.130 Transmission
cycles in Texas, although still poorly defined, have been studied more intensively than
any other region in the United States. Other states across the southern half of the country
have unknown endemic cycles, resulting in occurrence of seropositive wildlife, vectors,
and domestic dogs, alongside documented cases of clinical disease in dogs and people.
Clinical disease in dogs
Domestic dogs have been proposed as both sentinels for human disease16,112,118
and as animal models for Chagas’ cardiomyopathy,132 due to similarities in the clinical
course of disease in dogs and humans. Acute disease, characterized by parasitemia,
occurs between 3 and 17 days post-infection. Clinical signs may include
lymphadenopathy, acute myocarditis, lethargy, pale mucous membranes, and splenic or
hepatic enlargement, with damage occurring as trypanomastigotes rupture infected
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cells.103 Dogs less than 1 year of age tend to have more serious illness and higher
mortality due to severe cardiac disease, while older dogs may not demonstrate clinical
signs.92 About 80% of experimentally infected dogs developed transiently abnormal
electrocardiograms (ECGs).132
Following recovery from the acute phase, dogs enter the indeterminate phase
which is asymptomatic and may persist for the duration of the dog’s life. Parasitemia
usually ends by 30 days post-infection, at which time ECG findings are typically normal,
although exercise may induce arrhythmias. Unlike in humans, sudden death due to heart
failure is uncommon during the indeterminate phase.103 Progression to chronic disease
occurs with development of cardiac dilation and eventual right-sided or bilateral heart
failure. Dogs infected at 2 years of age or younger have rapid development of heart
disease within 1-2 years, while older dogs survive 3-5 years after infection.103
Experimentally infected dogs developed chronic diffuse fibrosing cardiomyopathy as
seen in human Chagas’ cardiomyopathy, which may be immunologically mediated.132
Meningoencephalitis is a less frequent clinical presentation resulting in weakness, ataxia,
and hyperreflexia which can be mistaken for canine distemper.103
Treatment for dogs with American trypanosomiasis is similar to that used for
people. Benznidazole results in fewer adverse side effects than nifurtimox and is typically
given in conjunction with prednisone for acute disease, although no drugs have been
approved by the FDA for use in dogs. Current protocols reduce parasitemia but may not
result in serorecovery or prevent progression to chronic disease.112 Treatment during the
chronic stage is focused on mediating the signs of heart failure. Dogs diagnosed with
trypanosomiasis generally have a poor prognosis, and euthanasia may be warranted due
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to zoonotic risk.103 Prevention and control measures include reduction of exposure to
vectors or sylvatic hosts. Insecticides applied to dog housing areas or directly
administered have shown varying efficacy, with subcutaneous ivermectin purportedly
being more effective than fipronil impregnated collars.112 Integrated pest management,
including use of barriers, altering outside lighting, and housing dogs inside at night, may
allow for implementable risk reduction.129 Serological screening of blood donor dogs and
breeding bitches is recommended to reduce transmission in endemic areas.103
Diagnostic testing
Diagnostic testing is similar for both dogs and humans, and is dependent on the
clinical stage of disease. In acute disease (or early congenital infection), circulating
trypanomastigotes can be observed on blood smears, however, observation of the buffy
coat stained with Wright’s or Giemsa improves diagnostic sensitivity.103 Hemoculture
and PCR techniques have also been developed but are not widely available and increase
diagnostic time.92 Acute disease is most commonly recognized in dogs with sudden death
due to cardiomyopathy and may be confirmed via histopathology.129
Serology is used to diagnosis chronic infection, with development of detectable
IgG antibody within 4 weeks of infection in dogs.28 Clinical signs which may prompt
testing for chronic Chagas’ disease in dogs include cardiomegaly, decreased activity or
appetite, ascites, abnormal ECG findings, or other signs of cardiomyopathy.129 Several
serological tests have been used for diagnosis, including an immunofluorescent antibody
assay (IFA), enzyme-linked immunosorbent assay (ELISA), and
radioimmunoprecipitation assay (RIPA), however, all are prone to cross-reaction with
Leishmania spp.103 In humans, serological tests targeting two different antigens or using
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two different methods are applied in series (for blood screening) or parallel (for clinical
disease) to improve diagnostic specificity and sensitivity, respectively.92 The US Food
and Drug Administration has approved two tests to screen human blood donors: an
ELISA in 2006 and a recombinant chemiluminescent immunoassay in 2010. Both tests
require repeat-reactive results to remove a blood donor from eligibility, and positives are
usually confirmed via RIPA. Human clinical cases are diagnosed by the CDC through a
combination of tests including an in-house IFA, a commercial ELISA, or an immunoblot
assay.93
In addition to conventional testing, recent studies have investigated the use of
immunochromatographic tests in people, domestic dogs,16,133-135 and wild canids.136-137
These screening tests are rapid, simple to perform in the field, and do not require
specialized equipment or technical skills.133 A commercial canine dipstick test using
recombinant T. cruzi antigens (Trypanosoma DetectTM MRA Rapid Test; Inbios
International Ltd., Seattle, Washington) showed a sensitivity and specificity of 91% and
98%, respectively, in experimentally infected dogs from the United States.135 A human
commercial cassette test using recombinant protein conjugated to dye (Chagas STATPAK; Chembio Diagnostic Systems, Medford, New York) had perfect agreement with
the IFAT performed by the CDC on 50 canine serum samples, and performed slightly
better than the dipstick test which had perfect sensitivity and 95% specificity.134 Both
tests are practical, economical alternatives for serological screening of dog populations.
Prevalence of T. cruzi in dogs in the United States
Prevalence of T. cruzi is poorly documented for dogs in the United States. Reports
of population level prevalence vary widely based on the population tested and diagnostic
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test(s) used, making comparisons across studies difficult (Table 1.4). In addition, several
previous reports have used convenience sampling which may not be representative of the
overall dog population. Studies may also suffer from lack of geographic resolution due to
low statistical power; Tenney et al. did not detect any regional differences in dogs across
Texas, however, sample sizes from each district were small (<30 dogs).16 Vector-borne
diseases such as Chagas’ may occur at uneven rates, with pockets of hyperendemicity
occurring where there is convergence of suitable vector habits, high populations of
reservoir hosts, and higher rates of disease and transmission.21 Systematic, intensive
sampling may be required to detect important differences in regional transmission and
dog risk factors for disease.
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Table 1.4
State
SE
US

LA

VA

OK
TX

LA

TX

Seroprevalence of T. cruzi in dogs in the United States

Population
Random samples
collected from patients
at 3 institutions;
samples were from GA
(309), SC (29), NC
(19), VA (4), LA (2),
FL (1), WV (1)
85 dogs from rural
environment with host
exposure; 103 dogs
from rural without host
exposure; 176 dogs
from urban animal
shelter; 100 pet dogs
from urban housing
Mother and 7 of 8
puppies positive; 12
dogs from area of index
case; 52 dogs in the
county
Owned and impounded
stray dogs (selection
criteria undefined)
Convenience sample of
healthy dogs >6 months
of age in Harris
County, TX and
surrounding regions
Group 1: three kennels
with previous positive
dogs; Group 2:
convenience samples
from veterinary clinics
in area with reported
Chagas’ in dogs
Dogs from 7 shelters
across TX

Test Used
Direct
agglutination
(DA),
positives
tested with
complement
fixation (CF)
ELISA

Sample size
365

Prevalence
6.6% for DA,
1.9% for CF

Citation
Tomlinson
et al.,
1981138

464

4.7% in rural
with known
host contact,
2.3% in
shelter

Barr et al.,
199128

ELISA and
RIPA

64 plus
index case
and litter

3.8% (2 of 52
dogs sampled
from county)

Barr et al.,
1995117

RIPA

304

3.6%

Bradley et
al., 2000139

ELISA +
flow
cytometry

356

2.6%

Shadomy
et al.,
2004140

IFAT

Group 1: 31
total (15, 8,
8 from each
of 3
kennels)
Group 2: 91

Group 1:
51.6% (60%,
25%, 62.5%,
respectively)
Group 2:
12%

Nieto et al.,
2009134

STAT-PAK

205

8.8%

Tenney et
al., 201416

Studies are listed chronologically by publication date.
Data from Mississippi is lacking for Chagas’ disease. No studies have measured
seroprevalence in dogs within the state, and limited information is available on
occurrence in wildlife and triatomine vectors.92 There have been comparatively few
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human Chagas’ cases in Mississippi found during blood donation screening, with only 9
of the 2281 confirmed positives in the AABB Biovigilance Network reported from
Mississippi in the past 10 years.141 However, these low numbers likely reflect a smaller
Latin America immigrant population in which the majority of positives occur. Of note,
two Mississippi natives were identified as probable autochthonous cases shortly after
widespread blood donor screening was implemented and triggered The United States
Trypanosoma cruzi Infection Study by the CDC.93 Human cases in Mississippi may
therefore represent a greater occurrence of indigenously acquired disease than most other
states. Data on the seroprevalence of T. cruzi in transmission cycle components across the
state, including domestic dogs, triatomine insects, and wildlife hosts, may prove useful in
assessment of public health risk.
Conclusions
Many authors have recognized the potential of domestic dogs as sentinels for
American Trypanosomiasis in both South America and the United States.16,112,118,130
Humans are primarily infected through domestic transmission cycles, and dogs are ideal
sentinels for these cycles in that they are comparatively easy to sample and diagnostic tests
are increasingly available. Prevalence of disease, and therefore efficiency of surveillance
testing to detect areas where disease is endemic, is likely greater in dogs than in humans.
In particular, free-ranging dogs or those housed predominately outdoors may have greater
rates of infection due to triatomine exposure, both by insects feeding on dogs and
alternative routes of transmission such as ingestion of triatomines. It is logistically
challenging to perform surveillance sampling on free-ranging dogs, however, animal
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shelters provide convenient, large populations of dogs which can be easily and
economically sampled.
An appropriate sampling strategy is required to approximate the true
seroprevalence within a population. Inclusion criteria must be carefully defined to
prevent introduction of bias; many of the T. cruzi seroprevalence studies done in the
United States either do not define inclusion criteria for sampled dogs or have excluded
dogs less than 6 months of age. Information on this subset of the population is therefore
unknown. A better understanding of risk factors for being seropositive, such as age,
source (stray versus owner surrender), and apparent health status, may reveal important
criteria for targeted surveillance of high-risk individuals when the goal is to determine if
disease is present, rather than to evaluate seroprevalence. Additionally, clustering of
disease may occur by geographic region or even at a local level depending on disease
transmission factors. To capture these differences, sampling must be systematic and
provide high enough statistical power to detect differences. Stratified random testing of
shelter dogs on a state-wide level may help resolve important questions on T. cruzi
prevalence in Mississippi as an indication of autochthonous disease risk for both dogs
and humans.

47

References
1. AVMA. 2012 U.S. pet ownership and demographics sourcebook. Available at:
https://www.avma.org/KB/Resources/Statistics/Pages/Market-research-statisticsUS-pet-ownership.aspx?PF=1. Accessed November 17, 2017.
2. APPA. American Pet Products Association, Inc. National Pet Owners Survey 20172018. Available at:
http://americanpetproducts.org/Uploads/MemServices/GPE2017_NPOS_Seminar.
pdf. Accessed November 17, 2017.
3. Patronek GJ, Rowan AN. Determining dog and cat numbers and population dynamics.
Anthrozoos 1995;8:199–205.
4. Marx MB, Furcolow ML. What is the dog population? Archives of Environmental
Health 1969;19:217–219.
5. Griffiths A, Brenner A. Survey of cat and dog ownership in Champaign County,
Illinois, 1976. Journal of the American Veterinary Medical Association
1977;170:1333–1340.
6. Nassar R, Mosier JE. Canine population dynamics: a study of the Manhattan, Kansas,
canine population. American Journal of Veterinary Research 1980;41:1798–1803.
7. Leslie BE, Meek AH, Kawash GF, et al. An epidemiological investigation of pet
ownership in Ontario. The Canadian Veterinary Journal 1994;35:218.
8. Rowan AN. Companion animal demographics and unwanted animals in the United
States. Anthrozoos 1992;5:222–225.
9. Patronek GJ, Glickman LT. Development of a model for estimating the size and
dynamics of the pet dog population. Anthrozoos 1994;7:25–42.
10. Woodruff K, Smith DR. An estimate of the number of dogs in US shelters. Available
at: http://c.ymcdn.com/sites/www.sawanetwork.org/resource/resmgr/Conferences/
An_Estimate_of_Number_of_Dog.pdf. Accessed November 17, 2017.
11. Lord LK, Wittum TE, Ferketich AK, et al. Demographic trends for animal care and
control agencies in Ohio from 1996 to 2004. Journal of the American Veterinary
Medical Association 2006;229:48–54.
12. ASPCA. American Society for the Prevention of Cruelty to Animals. Shelter intake
and surrender: Pet statistics. Available at: https://www.aspca.org/animalhomelessness/shelter-intake-and-surrender/pet-statistics. Accessed November 22,
2017.

48

13. Zawistowski S, Morris J, Salman MD, et al. Population dynamics, overpopulation,
and the welfare of companion animals: New insights on old and new data. Journal
of Applied Animal Welfare Science 1998;1:193–206.
14. Scarlett JM. Interface of epidemiology, pet population issues and policy. Preventive
Veterinary Medicine 2008;86:188–197.
15. Salman MD, New Jr JC, Scarlett JM, et al. Human and animal factors related to the
relinquishment of dogs and cats in 12 selected animal shelters in the United
States. Journal of Applied Animal Welfare Science 1998;1(3):207-226.
16. Tenney TD, Curtis-Robles R, Snowden KF, et al. Shelter dogs as sentinels for
Trypanosoma cruzi transmission across Texas. Emerging Infectious Diseases
2014;20:1323–1326.
17. Kile JC, Panella NA, Komar N, et al. Serologic survey of cats and dogs during an
epidemic of West Nile virus infection in humans. Journal of the American
Veterinary Medical Association 2005;226:1349–1353.
18. Marsh P. Replacing myth with math: Using evidence-based programs to eradicate
shelter overpopulation. Town and Country Reprographics; 2010. Available at:
http://shelteroverpopulation.org/Books/Replacing_Myth_with_Math.pdf.
Accessed January 9, 2018.
19. Levy JK, Lappin MR, Glaser AL, et al. Prevalence of infectious diseases in cats and
dogs rescued following Hurricane Katrina. Journal of the American Veterinary
Medical Association 2011;238:311–317.
20. Little SE, Johnson EM, Lewis D, et al. Prevalence of intestinal parasites in pet dogs
in the United States. Veterinary Parasitology 2009;166:144–152.
21. Bowman D, Little SE, Lorentzen L, et al. Prevalence and geographic distribution of
Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma
phagocytophilum in dogs in the United States: Results of a national clinic-based
serologic survey. Veterinary Parasitology 2009;160:138–148.
22. Hollett RB. Canine brucellosis: Outbreaks and compliance. Theriogenology
2006;66:575–587.
23. Brower A, Okwumabua O, Massengill C, et al. Investigation of the spread of Brucella
canis via the U.S. interstate dog trade. International Journal of Infectious
Diseases 2007;11:454–458.
24. Macintire DK, Boudreaux MK, West GD, et al. Babesia gibsoni infection among
dogs in the southeastern United States. Journal of the American Veterinary
Medical Association 2002;220:325–329.
49

25. Lim S, Irwin PJ, Lee S, et al. Comparison of selected canine vector-borne diseases
between urban animal shelter and rural hunting dogs in Korea. Parasites &
Vectors 2010;3:32.
26. Brown J, Blue JL, Wooley RE, et al. A serologic survey of a population of Georgia
dogs for Brucella canis and an evaluation of the slide agglutination test. Journal
of the American Veterinary Medical Association 1976;169:1214–1216.
27. Merino FJ, Serrano JL, Saz JV, et al. Epidemiological characteristics of dogs with
Lyme borreliosis in the province of Soria (Spain). European Journal of
Epidemiology 2000;16:97–100.
28. Barr SC, Dennis VA, Klei TR. Serologic and blood culture survey of Trypanosoma
cruzi infection in four canine populations of southern Louisiana. American
Journal of Veterinary Research 1991;52:570–573.
29. Tsai H-J, Huang H-C, Lin C-M, et al. Salmonellae and Campylobacters in household
and stray dogs in northern Taiwan. Veterinary Research Communications
2007;31:931–939.
30. Eriksson P, Loberg J, Andersson M, et al. A survey of cat shelters in Sweden. Animal
Welfare 2009;18:283–288.
31. Stavisky J, Brennan ML, Downes M, et al. Demographics and economic burden of
un-owned cats and dogs in the UK: results of a 2010 census. BMC Veterinary
Research 2012;8:163.
32. Hart LA, Takayanagi T, Yamaguchi C. Dogs and cats in animal shelters in Japan.
Anthrozoos 1998;11:157–163.
33. D’Anastasio R, Zipfel B, Moggi-Cecchi J, et al. Possible brucellosis in an early
hominin skeleton from Sterkfontein, South Africa. Vitzthum VJ, ed. PLoS ONE
2009;4:e6439.
34. Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human
brucellosis. The Lancet Infectious Diseases 2006;6:91–99.
35. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: A re-emerging zoonosis.
Veterinary Microbiology 2010;140:392–398.
36. Godfroid J, Cloeckaert A, Liautard J-P, et al. From the discovery of the Malta fever's
agent to the discovery of a marine mammal reservoir, brucellosis has continuously
been a re-emerging zoonosis. Veterinary Research 2005;36:313–326.
37. Godfroid J, Scholz HC, Barbier T, et al. Brucellosis at the animal/ecosystem/human
interface at the beginning of the 21st century. Preventive Veterinary Medicine
2011;102:118–131.
50

38. Vrioni G, Pappas G, Priavali E, et al. An eternal microbe: Brucella DNA load persists
for years after clinical cure. Clinical Infectious Diseases 2008;46:e131–e136.
39. Whatmore AM. Current understanding of the genetic diversity of Brucella, an
expanding genus of zoonotic pathogens. Infection, Genetics and Evolution
2009;9:1168–1184.
40. Pappas G. The changing Brucella ecology: novel reservoirs, new threats.
International Journal of Antimicrobial Agents 2010;36:S8–S11.
41. Memish ZA, Balkhy HH. Brucellosis and international travel. Journal of Travel
Medicine 2004;11:49–55.
42. Carmichael LE, Shin SJ. Canine brucellosis: A diagnostician’s dilemma. Seminars in
Veterinary Medicine and Surgery (Small Animal) 1996;11:161–165.
43. Carmichael LE. Canine brucellosis: An annotated review with selected cautionary
comments. Theriogenology 1976;6:105–116.
44. Gyuranecz M, Szeredi L, Ronai Z, et al. Detection of Brucella canis-induced
reproductive diseases in a kennel. Journal of Veterinary Diagnostic Investigations
2011;23:143–147.
45. Nielsen K. Diagnosis of brucellosis by serology. Veterinary Microbiology
2002;90:447–459.
46. OIE. World Organization for Animal Health. Terrestrial manual chapter 2.8.5:
Porcine brucellosis. Available at http://www.oie.int/international-standardsetting/terrestrial-manual/. Accessed July 11, 2017.
47. Monroe PW, Silberg SL, Morgan PM, et al. Seroepidemiological investigation of
Brucella canis antibodies in different human population groups. Journal of
Clinical Microbiology 1975;2:382–386.
48. Ledbetter EC, Landry MP, Stokol T, et al. Brucella canis endophthalmitis in 3 dogs:
clinical features, diagnosis, and treatment. Veterinary Ophthalmology
2009;12:183–191.
49. Keid LB, Soares RM, Vasconcellos SA, et al. Comparison of agar gel
immunodiffusion test, rapid slide agglutination test, microbiological culture and
PCR for the diagnosis of canine brucellosis. Research in Veterinary Science
2009;86:22–26.
50. Zoetis Inc. D-TEC CB: Canine brucellosis antibody test kit. 2014. Available at:
https://www.zoetisus.com/_locale-assets/dog/diagnostics/d-tec_cb.pdf. Accessed
November 15, 2017.
51

51. Barr S, Eilts B, Roy A, et al. Brucella suis biotype 1 infection in a dog. Journal of the
American Veterinary Medical Association 1986;189:686–687.
52. Ramamoorthy S, Woldemeskel M, Ligett A, et al. Brucella suis infection in dogs,
Georgia, USA. Emerging Infectious Diseases 2011;17:2386–2387.
53. Forbes L. Brucella abortus infection in 14 farm dogs. Journal of the American
Veterinary Medical Association 1990;196:911–916.
54. Baek BK, Lim CW, Rahman MS, et al. Brucella abortus infection in indigenous
Korean dogs. Canadian Journal of Veterinary Research 2003;67:312–314.
55. Woldemeskel M. Zoonosis due to Brucella suis with special reference to infection in
dogs (carnivores): A brief review. Open Journal of Veterinary Medicine
2013;03:213–221.
56. Neiland KA, Miller LG. Experimental Brucella suis Type 4 infections in domestic
and wild Alaskan carnivores. Journal of Wildlife Diseases 1981;17:183–189.
57. Wanke MM, Delpino MV, Baldi PC. Use of enrofloxacin in the treatment of canine
brucellosis in a dog kennel (clinical trial). Theriogenology 2006;66:1573–1578.
58. Anderson GI, Binnington AG. Discospondylitis and orchitis associated with high
Brucella titre in a dog. Canadian Veterinary Journal 1983;24:249–252.
59. Mateu-de-Antonio EM, Martin M. In vitro efficacy of several antimicrobial
combinations against Brucella canis and Brucella melitensis strains isolated from
dogs. Veterinary Microbiology 1995;45:1–10.
60. Zoha SJ, Walsh R. Effect of a two-stage antibiotic treatment regimen on dogs
naturally infected with Brucella canis. Journal of the American Veterinary
Medical Association 1982;180:1474–1475.
61. Nicoletti P. Further studies on the use of antibiotics in canine brucellosis. The
Compendium on Continuing Education for the Practicing Veterinarian
1991;13:944–946.
62. Flores CR, Carmichael LE. Brucella canis infection in dogs: treatment trials. Revista
Latino Americana de Microbiologia 1981;23:75–79.
63. Carmichael LE. Abortion in 200 beagles. Journal of the American Veterinary
Medical Association 1966;149:1126.
64. Moore JA, Bennett M. A previously undescribed organism associated with canine
abortion. Veterinary Research 1967;80:604–605.

52

65. Carmichael LE, Kenney RM. Canine abortion caused by Brucella canis. Journal of
the American Veterinary Medical Association 1968;152:605–616.
66. Swenson RM, Carmichael LE, Cundy KR. Human infection with Brucella canis.
Annals of Internal Medicine 1972;76:435–438.
67. Lucero NE, Corazza R, Almuzara MN, et al. Human Brucella canis outbreak linked
to infection in dogs. Epidemiology and Infection 2010;138:280.
68. Watson JA. Administrative procedures notice filing 22077. Available at:
http://sos.ms.gov/ACProposed/00022077a.pdf. Accessed July 12, 2017.
69. Hoff G, Nichols JB. Canine brucellosis in Florida: serologic survey of pound dogs,
animal shelter workers and veterinarians. American Journal of Epidemiology
1974;100:35–39.
70. Fredrickson LE, Barton CE. A serologic survey for canine brucellosis in a
metropolitan area. Journal of the American Veterinary Medical Association
1974;165:987–989.
71. Lovejoy GS, Carver HD, Moseley IK, et al. Serosurvey of dogs for Brucella canis
infection in Memphis, Tennessee. American Journal of Public Health
1976;66:175–176.
72. Galphin SPJ. A serologic survey for Brucella canis in dogs on a military base.
Journal of the American Veterinary Medical Association 1977;171:728–729.
73. Higgins R, Hoquet F, Bourque R, et al. A serological survey for Brucella canis in
dogs in the province of Quebec. Canadian Veterinary Journal 1979;20:315–317.
74. Boebel FW, Ehrenford FA, Brown GM, et al. Agglutinins to Brucella canis in stray
dogs from certain counties in Illinois and Wisconsin. Journal of the American
Veterinary Medical Association 1979;175:276–277.
75. Thiermann AB. Brucellosis in stray dogs in Detroit. Journal of the American
Veterinary Medical Association 1980;177:1216–1217.
76. Bosu WTK, Prescott JF. A serological survey of dogs for Brucella canis in
southwestern Ontario. The Canadian Veterinary Journal 1980;21:198.
77. Pue HL. Serosurvey for the prevalence of Brucella canis antibodies in dogs in central
Ohio. Available at http://www.dtic.mil/dtic/tr/fulltext/u2/a126956.pdf. Accessed
November 10, 2017.
78. Witmer GW, Sanders RB, Taft AC. Feral swine - are they a disease threat to livestock
in the United States? USDA National Wildlife Research Center-Staff Publications
2003:292.
53

79. Hutton T, DeLiberto T, Owen S, et al. Disease risks associated with increasing feral
swine numbers and distribution in the United States. 2006. Available at:
http://digitalcommons.unl.edu/michbovinetb/59/?a_aid=3598aabf. Accessed
September 25, 2015.
80. Seward NW, VerCauteren KC, Witmer GW, et al. Feral swine impacts on agriculture
and the environment. Sheep & Goat Research Journal 2004:12.
81. Aparicio ED. Epidemiology of brucellosis in domestic animals caused by Brucella
melitensis, Brucella suis and Brucella abortus. Scientific and Technical Review of
the Office International des Epizooties 2013;32:53–60.
82. Pedersen K, Quance CR, Robbe-Austerman S, et al. Identification of Brucella suis
from feral swine in selected states in the USA. Journal of Wildlife Diseases
2014;50:171–179.
83. Wyckoff AC, Henke SE, Campbell TA, et al. Feral swine contact with domestic
swine: A serologic survey and assessment of potential for disease transmission.
Journal of Wildlife Diseases 2009;45:422–429.
84. Plang JF, Huddleson IF. Brucella infection in a dog. Journal of the American
Veterinary Medical Association 1931;79:251–252.
85. Pedersen K, Bevins SN, Schmit BS, et al. Apparent prevalence of swine brucellosis in
feral swine in the United States. USDA National Wildlife Research Center - Staff
Publications. Spring 2012. Available at: http://digitalcommons.unl.edu/icwdm_
usdanwrc/1175/. Accessed September 25, 2015.
86. Chagas C. Nova tripanozomiaze humana. Estudoes a sobre a morfolojia e o ciclo
evolutivo do Schizotrypanum cruzi n.gen. n.sp., ajente etiolojico de nova entidade
do homem. Memórias do Instituto Oswaldo Cruz 1909;1:159–218.
87. WHO. World Health Organization. Global health estimates 2015: Disease burden by
cause, age, sex, by country and by region, 2000-2015. Available at:
http://www.who.int/healthinfo/global_burden_disease/en/. Accessed October 13,
2017.
88. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United
States. Clinical Infectious Diseases 2009;49:e52–e54.
89. Heymann DL. Control of communicable diseases manual. 18th ed. Washington DC:
American Public Health Association; 2004.
90. Yadon ZE, Schmunis GA. Congenital Chagas disease: Estimating the potential risk in
the United States. American Journal of Tropical Medicine and Hygiene
2009;81:927–933.
54

91. Shikanai-Yasuda MA, Carvalho NB. Oral transmission of Chagas disease. Clinical
Infectious Diseases 2012;54:845–852.
92. Bern C, Kjos S, Yabsley MJ, et al. Trypanosoma cruzi and Chagas’ disease in the
United States. Clinical Microbiology Reviews 2011;24:655–681.
93. Cantey PT, Stramer SL, Townsend RL, et al. The United States Trypanosoma cruzi
infection study: evidence for vector-borne transmission of the parasite that causes
Chagas disease among United States blood donors. Transfusion 2012;52:1922–
1930.
94. Bern C. Chagas’ disease. Longo DL, ed. New England Journal of Medicine
2015;373:456–466.
95. Nunes MCP, Dones W, Morillo CA, et al. Chagas disease. Journal of the American
College of Cardiology 2013;62:767–776.
96. CDC. Centers for Disease Control and Prevention. Chagas disease - antiparasitic
treatment. Available at:
https://www.cdc.gov/parasites/chagas/health_professionals/tx.html. Accessed
October 12, 2017.
97. Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for
chronic Chagas’ cardiomyopathy. New England Journal of Medicine
2015;373:1295–1306.
98. WHO. World Health Organization. Chagas disease control strategy. Available at:
http://www.who.int/chagas/strategy/en/. Accessed October 13, 2017.
99. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin
America and future challenges in epidemiology, surveillance and health policy.
Memórias do Instituto Oswaldo Cruz 2009;104:17–30.
100. Stanaway JD, Roth G. The burden of Chagas disease: estimates and challenges.
Global Heart 2015;10:139–144.
101. Lee BY, Bacon KM, Bottazzi ME, et al. Global economic burden of Chagas disease:
a computational simulation model. The Lancet Infectious Diseases 2013;13:342–
348.
102. Montgomery SP, Starr MC, Edwards MS, et al. Neglected parasitic infections in the
United States: Chagas disease. The American Journal of Tropical Medicine and
Hygiene 2014;90:814–818.
103. Barr SC. Canine Chagas’ disease (American Trypanosomiasis) in North America.
Veterinary Clinics of North America: Small Animal Practice 2009;39:1055–1064.
55

104. CDC. Centers for Disease Control and Prevention. Laboratory identification of
parasitic Diseases of public health concern: American Trypanosomiasis.
Available at: https://www.cdc.gov/dpdx/trypanosomiasisamerican/index.html.
Accessed October 18, 2017.
105. Momen H. Taxonomy of Trypanosoma cruzi: a commentary on characterization and
nomenclature. Memórias do Instituto Oswaldo Cruz 1999;94:181–184.
106. Miles M, Toye P, Oswald S, et al. The identification by isoenzyme patterns of two
distinct strain-groups of Trypanosoma cruzi, circulating independently in a rural
area of Brazil. Transactions of the Royal Society of Tropical Medicine and
Hygiene 1977;71:217–225.
107. Brisse S, Verhoef J, Tibayrenc M. Characterization of large and small subunit rRNA
and mini-exon genes further supports the distinction of six Trypanosoma cruzi
lineages. International Journal for Parasitology 2001;31:1218–1226.
108. Roellig DM, Brown EL, Barnabé C, et al. Molecular typing of Trypanosoma cruzi
isolates, United States. Emerging Infectious Diseases 2008;14:1123–1125.
109. Barnabé C, Yaeger R, Pung O, et al. Trypanosoma cruzi: A considerable
phylogenetic divergence indicates that the agent of Chagas disease is indigenous
to the native fauna of the United States. Experimental Parasitology 2001;99:73–
79.
110. Miles MA, Llewellyn MS, Lewis MD, et al. The molecular epidemiology and
phylogeography of Trypanosoma cruzi and parallel research on Leishmania:
looking back and to the future. Parasitology 2009;136:1509.
111. Jansen AM, Xavier SCC, Roque ALR. The multiple and complex and changeable
scenarios of the Trypanosoma cruzi transmission cycle in the sylvatic
environment. Acta Tropica 2015;151:1–15.
112. Gürtler RE, Cardinal MV. Reservoir host competence and the role of domestic and
commensal hosts in the transmission of Trypanosoma cruzi. Acta Tropica
2015;151:32–50.
113. Kjos SA, Marcet PL, Yabsley MJ, et al. Identification of bloodmeal sources and
Trypanosoma cruzi infection in Triatomine bugs (Hemiptera: Reduviidae) from
residential settings in Texas, the United States. Journal of Medical Entomology
2013;50:1126–1139.
114. Kribs-Zaleta C. Estimating contact process saturation in sylvatic transmission of
Trypanosoma cruzi in the United States. Rodriguez A, ed. PLoS Neglected
Tropical Diseases 2010;4:e656.

56

115. Zeledon R, Alvarado R, Jiron L. Observations on the feeding and defecation patterns
of three triatomine species (Hemiptera: Reduviidae). Acta Tropica 1977;34:65–
77.
116. Roellig DM, Ellis AE, Yabsley MJ. Oral transmission of Trypanosoma cruzi with
opposing evidence for the theory of carnivory. Journal of Parasitology
2009;95:360–364.
117. Barr SC, Van Beek O, Carlisle-Nowak MS, et al. Trypanosoma cruzi infection in
Walker hounds from Virginia. American Journal of Veterinary Research
1995;56:1037–1044.
118. Castañera MB, Lauricella MA, Chuit R, et al. Evaluation of dogs as sentinels of the
transmission of Trypanosoma cruzi in a rural area of north-western Argentina.
Annals of Tropical Medicine & Parasitology 1998;92:671–683.
119. Brown EL, Roellig DM, Gompper ME, et al. Seroprevalence of Trypanosoma cruzi
among eleven potential reservoir species from six states across the southern
United States. Vector-Borne and Zoonotic Diseases 2010;10:757–763.
120. Navin TR, Roberto RR, Juranek DD, et al. Human and sylvatic Trypanosoma cruzi
infection in California. American Journal of Public Health 1985;75:366–369.
121. Pung OJ, Banks CW, Jones DN, et al. Trypanosoma cruzi in wild raccoons,
opossums, and Triatomine bugs in Southeast Georgia, U.S.A. The Journal of
Parasitology 1995;81:324.
122. Yaeger RG. The prevalence of Trypanosoma cruzi infection in armadillos collected
at a site near New Orleans, Louisiana. The American Journal of Tropical
Medicine and Hygiene 1988;38:323–326.
123. Dorn PL, Perniciaro L, Yabsley MJ, et al. Autochthonous transmission of
Trypanosoma cruzi, Louisiana. Emerging Infectious Diseases 2007;13:605.
124. Ramírez JD, Turriago B, Tapia-Calle G, et al. Understanding the role of dogs (Canis
lupus familiaris) in the transmission dynamics of Trypanosoma cruzi genotypes in
Colombia. Veterinary Parasitology 2013;196:216–219.
125. Cohen JE, Gürtler RE. Modeling household transmission of American
trypanosomiasis. Science 2001;293:694–698.
126. Gürtler RE, Cecere MC, Rubel DN, et al. Chagas disease in north-west Argentina:
infected dogs as a risk factor for the domestic transmission of Trypanosoma cruzi.
Transactions of the Royal Society of Tropical Medicine and Hygiene
1991;85:741–745.

57

127. Gürtler R, Cecere MC, Lauricella M, et al. Domestic dogs and cats as sources of
Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology
2007;134:69–82.
128. Beard CB, Pye G, Steurer FJ, et al. Chagas disease in a domestic transmission cycle
in southern Texas, USA. Emerging Infectious Diseases 2003;9:103–105.
129. Kjos SA, Snowden KF, Craig TM, et al. Distribution and characterization of canine
Chagas disease in Texas. Veterinary Parasitology 2008;152:249–256.
130. Hanford EJ, Zhan FB, Lu Y, et al. Chagas disease in Texas: Recognizing the
significance and implications of evidence in the literature. Social Science &
Medicine 2007;65:60–79.
131. Kjos SA, Snowden KF, Olson JK. Biogeography and Trypanosoma cruzi infection
prevalence of Chagas disease vectors in Texas, USA. Vector-Borne and Zoonotic
Diseases 2009;9:41–50.
132. De Lana M, Chiari E, Tafuri WL. Experimental Chagas’ disease in dogs. Memórias
do Instituto Oswaldo Cruz 1992;87:59–71.
133. Luquetti AO, Ponce C, Ponce E, et al. Chagas’ disease diagnosis: a multicentric
evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with
recombinant proteins of Trypanosoma cruzi. Diagnostic Microbiology and
Infectious Disease 2003;46:265–271.
134. Nieto PD, Boughton R, Dorn PL, et al. Comparison of two immunochromatographic
assays and the indirect immunofluorescence antibody test for diagnosis of
Trypanosoma cruzi infection in dogs in south central Louisiana. Veterinary
Parasitology 2009;165:241–247.
135. Rosypal AC, Hill R, Lewis S, et al. Evaluation of a rapid immunochromatographic
dipstick test for detection of antibodies to Trypanosoma cruzi in dogs
experimentally infected with isolates obtained from opossums (Didelphis
virginiana), armadillos (Dasypus novemcinctus), and dogs (Canis familiaris) from
the United States. Journal of Parasitology 2011;97:140–143.
136. Rosypal AC, Tidwell RR, Lindsay DS. Prevalence of antibodies to Leishmania
infantum and Trypanosoma cruzi in wild canids from South Carolina. Journal of
Parasitology 2007;93:955–957.
137. Rosypal AC, Smith T, Alexander A, et al. Serologic survey of antibodies to
Trypanosoma cruzi in coyotes and red foxes from Pennsylvania and Tennessee.
Journal of Zoo and Wildlife Medicine 2014;45:991–993.

58

138. Tomlinson M, Chapman WJ, Hanson W, et al. Occurrence of antibody to
Trypanosoma cruzi in dogs in the southeastern United States. American Journal
of Veterinary Research 1981;42:1444–1446.
139. Bradley KK, Bergman DK, Woods JP, et al. Prevalence of American
trypanosomiasis (Chagas disease) among dogs in Oklahoma. Journal of the
American Veterinary Medical Association 2000;217:1853–1857.
140. Shadomy SV, Waring SC, Chappell CL. Combined use of enzyme-linked
immunosorbent assay and flow cytometry to detect antibodies to Trypanosoma
cruzi in domestic canines in Texas. Clinical and Vaccine Immunology
2004;11:313–319.
141. AABB. AABB Chagas Biovigilance Network. Available at:
http://www.aabb.org/research/hemovigilance/Pages/chagas.aspx. Accessed
November 1, 2017.

59

CHAPTER II
MISSISSIPPI ANIMAL SHELTER CENSUS AND CANINE SERUM BANK FOR
POPULATION-BASED SEROPREVALENCE RESEARCH

(Prepared for submission to the Journal of the
American Veterinary Medical Association)

Kristina J. Hubbard1, Uri B. Donnett2, Christina M. Loftin2, Frank W. Austin1,
Kimberly A. Woodruff2, and David R. Smith1

1

Department of Pathobiology and Population Medicine, College of Veterinary Medicine,
Mississippi State University, Mississippi State, MS, USA.
2

Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State
University, Mississippi State, MS, USA.

60

Abstract
Objective: To develop a representative serum bank for population-based seroprevalence
studies
Design: Census of animal shelters followed by cross-sectional collection of serum
samples
Population: 61 shelters in 45 counties identified in census; 571 dogs over 8 weeks of age
proportionately sampled from 9 geographic districts for serum bank
Procedures: Organizations believed to be animal shelters in Mississippi were compiled
from existing lists and web-based searches. Information on animal intake and shelter
practices was obtained by phone or other contact. Organizations with a physical facility
and offering public adoptions were classified as shelters, and used to determine dog
intake for 9 geographic districts during 2015. Blood and physical examination
information was collected for randomly selected dogs in 18 shelters, proportionately
sampled from each district based on the shelter dog population identified in the census.
Serum was frozen in aliquots for future seroprevalence research. Summary statistics for
animal shelters and sampled dogs are presented.
Results: The 61 animal shelters in Mississippi had a combined intake of over 56,000
dogs in 2015. Shelters varied widely in size, and dog intake was correlated to human
population by district (R2=0.91). Over half of shelters used foster homes for animals, and
37% of shelters had transport programs for dogs. Average annual dog adoption rate by
shelter was 55%.
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A serum bank was established containing 571 dog samples, of which 36% came
from puppies (less than 6 months of age). Dogs had a variety of health abnormalities,
with coat and skin problems being most common.
Conclusions and Clinical Relevance: This is the first report of the shelter dog
population and distribution in Mississippi, providing a baseline to monitor future trends
in intake and adoption. Additionally, banked sera provides a rare opportunity for disease
prevalence estimation from randomly collected samples to minimize bias. Knowledge of
the prevalence of diseases in the Mississippi shelter dog population should guide public
policy and shelter risk management.

Key Words: animal shelter, census, canine serum bank
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Introduction
Shelter animals are a unique population for disease surveillance with multiple risk
factors frequently contributing to higher rates of disease than seen in owned companion
animals. Animals often enter shelters as free-roaming strays with greater exposure to
other domestic and wild animal populations, are more likely to be sexually intact, and
may lack preventative care including vaccination and parasite control prior to shelter
intake.1 Additionally, these populations are often maintained in high density facilities
with variable levels of biosecurity and isolation. Although previous research has
identified risk factors contributing to animal relinquishment and shelter outcome,2-3
limited data is available on the health of animals within the shelter environment.
Knowledge of the prevalence of disease within this population is necessary to assess the
public health risk posed to animal shelter employees and adopters, and for effective
shelter allocation of resources to minimize disease transmission and occurrence.
Accurate measurements of disease require representative sampling of the
population of interest, which is dependent on an accurate sampling frame. Animal
shelters and their populations have been described as a “statistical black hole,” with
multiple and inconsistent estimates of both the number of animal shelters and the animal
population they house in the United States.4 Much of this confusion results from lack of
mandatory shelter facility registration in some states, the often transient nature of
volunteer-run or locally-financed operations, and lack of funding and organization to
maintain multistate lists. Additionally, a wide variety of facilities may house unowned
animals including humane societies, municipal animal control departments, animal
sanctuaries, and foster-based or breed-specific groups. Without a clear understanding of
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the characteristics and distribution of the animal shelter population, disease estimates are
usually determined by convenience sampling at one or a few shelters, which may not be
representative of the general shelter animal population. Furthermore, lack of wide-spread
systematic sampling may fail to identify important areas of high disease endemicity
within areas of lower occurrence.5
The Mississippi shelter dog population is highly mobile with both intrastate and
interstate travel for adoption through foster homes and transport programs with partner
shelters. Transported animals are usually screened for visible signs of disease and receive
routine diagnostic testing (e.g. heartworm and fecal parasite testing), but often do not
have comprehensive medical workups prior to transportation.6 Movement of these
animals may introduce diseases common in the southeastern United States to new areas,
or to low prevalence areas, and may pose a zoonotic disease risk. Previous reports have
shown higher rates of canine heartworm,5 canine brucellosis,7-9 and erlichiosis5 in the
Southeast. Also, there is some evidence for endemic canine leishmaniasis,10 Chagas’
disease,11 and babesiosis12 with competent vectors and wildlife reservoir species present
in the Southeast.
Prevalence of these diseases in the Mississippi shelter dog population is largely
unknown. Therefore, the objective of this study was to quantify and determine
distribution of the Mississippi shelter dog population in order to develop a representative
serum bank. Serum samples collected from shelter dogs across the state of Mississippi
provide a valuable research tool for population-based seroprevalence investigation of
infectious and zoonotic diseases.
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Materials and Methods
Prospective Shelter List
Registration of animal shelters is not currently required by the state of
Mississippi, thus a complete list of shelters in the state was not available. Two incomplete
lists of animal shelters and other animal organizations were obtained from the state Board
of Animal Health; one included shelters that had applied for funding from a specialty
license plate program operated through the Board of Animal Health and the other was
compiled by the Humane Society of the United States. A third list was generated by study
authors using multiple internet searches performed between December 2015 and March
2016 with the keywords “animal shelter”, “humane society”, and “animal control” for
each of the 82 counties in Mississippi.
Shelter Census
A phone census was attempted for each organization on the prospective shelter
list. One of three individuals conducted each survey following a written script which
introduced the caller, requested participation from the shelter director or other staff
member able to provide requested information, and gathered data on shelter contact
information, animal intake and adoption, and record keeping. Shelters were asked to
consult records, or, if records were unavailable, to provide a best estimate of the number
of dogs: which entered the shelter in 2015, were adopted to the public in 2015, were
currently housed at the shelter, and the sources from which dogs were received (owner
surrender, animal control/stray, transport/exchange, or other). Some organizations
requested a paper copy of the survey to aid in record analysis, and this was provided via
email. If repeated telephone contact attempts were unsuccessful, addition methods of
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communication were attempted, including email and private messaging on social media
sites.
Serum Bank Sampling
Stratified sampling was performed within the nine public health districts in
Mississippi to reflect the geographic distribution of dogs in the state. The percentage of
the total shelter dog population located in each district was used to proportionately
sample ~500 dogs for the serum bank. Sample size was selected to provide adequate
precision for a disease of low prevalence, specifically, canine brucellosis with an
estimated prevalence of 5% and desired precision of 1.5%. Clopper-Pearson exact
confidence intervals, chosen for increased accuracy at extreme values, are shown across
prevalence levels that may be present in future seroprevalence research (Figure 2.1). One
to three shelters were sampled per district based on previously established working
relationships, shelter willingness to participate, and logistic feasibility. For each shelter,
trained study personnel collected samples on a single day (a single shelter was sampled
twice to fill district quota, while ensuring that no dog was resampled on the second
collection visit).
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Figure 2.1

Clopper-Pearson exact 95% confidence intervals for serum bank

Seroprevalence disease estimate 95% CI based on a serum bank containing 571 samples.
Sample size was selected to provide precision of 0.015 for a disease with an expected
prevalence of 0.05.
Dogs were eligible for sampling if they were owned by the shelter (not in a
required hold period) and over 8 weeks of age. Within a shelter, dogs were randomly
selected for sampling; each eligible dog was assigned a consecutive number based on
housing location within the shelter, and a random number generatora was used to select
dogs. In some cases, the randomization scheme had to be modified. Individual dogs to be
sampled within group housing (of up to 4 dogs) were arbitrarily selected. If a sample
could not be safely obtained using mild manual restraint, the next randomly selected dog
was sampled as a replacement.
A brief physical examination was performed on all sampled dogs including an
estimate of the dog’s age, weight, and breed. Recorded information included sex, body
condition score (1-9), and a description of any examination abnormalities. A whole blood
sample of up to 20 milliliters was collected by vacutainer from the jugular or cephalic
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vein based on animal size and compliance. Samples were stored on ice during
transportation and processed within 24 hours of collection. Serum was collected after
centrifugation at 3000 rpm for 10 minutes and stored in 1 ml aliquots at -80°C.
Census Data Analysis
Following the census, all organizations were either designated a Mississippi
animal shelter or excluded from further analysis. For inclusion in our study, shelters must
have had a “brick-and-mortar” facility and offered animal adoptions to the public.
Organizations were excluded if they were duplicate entries under different names, were
foster-based only with no physical location, did not operate within the state of
Mississippi, were no longer active, or if web-based contact information failed to connect
to the organization.
Not all information was available for every shelter. Notably, some shelters did not
provide information on intake sources or record keeping systems. One shelter reported a
greater number of dogs adopted than received; this shelter was not included in analysis of
adoption rate since we do not know if this reflects data error, animals taken in during
previous years, or if this shelter does not consider some sources such as transported
animals as “received.”
Shelter locations were mapped using open-source geographic information
software.b Summary statistics were calculated using a commercial spreadsheet program.c
Multivariable linear regression of dog intake by district was modeled using candidate
explanatory variables of human population and average median household income by
district.d County level data were obtained from the 2015 estimates from the United States
Census Bureau,13 however, data were analyzed by district since many Mississippi
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counties did not have an animal shelter and these counties likely utilize nearby animal
shelters. Average household income by district was calculated from county median
household income weighted by county population.
Serum Bank Data Analysis
Physical examination data included both objective and subjective assessment at
the time of sample collection. Age was estimated by tooth eruption and wear, but was
also dichotomized during data analysis as puppy (<6 months of age) or adult (≥ 6 months
of age) based on eruption of secondary canine teeth. Empirical assessment of
predominant breed, recorded during examination, was used to classify dogs into the seven
American Kennel Club breed groups for analysis. Dogs with a body condition score of 4
or 5 out of 9 were considered ideal, with scores <4 and >5 classified as underweight and
overweight, respectively. Categorical statistics for sampled dogs, including sex, age,
breed, body condition, and health abnormalities, were reported as percentages. Data from
sampled dogs, along with corresponding source shelter information, were stored in a
database for serum bank management and detailed analysis of risk factors during future
seroprevalence research.
Results
Census
Of the 124 organizations on the initial prospective list, 61 facilities were
determined to be brick-and-mortar buildings which housed animals and offered public
adoption, meeting our definition for an animal shelter (Figure 2.2). Shelters were present
in 45 of Mississippi’s 82 counties, and each of the nine geographic districts contained
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between 4 and 10 shelters. The 61 shelters reported intake of 56,886 dogs in 2015 (Table
2.1). Shelters varied widely in size with a minimum of 45 and a maximum of 7,539 dogs
received during 2015 (Figure 2.3). Dog intake was associated with human population,
with shelters taking in 23 dogs per 1,000 people (SE=0.0028, R2=0.91, p<.0001), but was
not associated with median household income (p=0.68).

Figure 2.2

Distribution of 61 Mississippi animal shelters present in 2016

Shaded counties display the number and distribution of dogs sampled from 18 shelters for
the serum bank, proportionately sampled by shelter dog population within nine health
districts (Roman numerals).
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Table 2.1

Census shelter dog intake and dogs sampled for serum bank
Census Results

District
1
2
3
4
5
6
7
8
9

# of shelters
10
4
9
8
8
6
5
5
6
61

Dog Intake
5120
6316
3090
4727
12682
3095
3006
7086
11764
56886

Serum Bank
% of intake
9.0
11.1
5.4
8.3
22.3
5.4
5.3
12.5
20.7

Dogs sampled
57
64
33
56
108
30
32
77
114
571

% of sampled
10.0
11.2
5.8
9.8
18.9
5.3
5.6
13.5
20.0

TOTAL

3001 and more

2801-2900

2601-2700

2401-2500

2201-2300

2001-2100

1801-1900

1601-1700

1401-1500

1201-1300

1001-1100

801-900

601-700

401-500

201-300

10
9
8
7
6
5
4
3
2
1
0

100 and less

Count of Shelters

Dog intake for Mississippi animal shelters in 2015 by geographic district, and number of
dogs sampled by district for inclusion in the serum bank to reflect shelter dog distribution
across the state.

2015 Dog Intake

Figure 2.3

Frequency distribution of 61 shelters in Mississippi by 2015 dog intake
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Dog intake sources were available for 49 shelters. Owner surrender dogs were
accepted at 48 shelters (98%), and stray dogs were accepted at 48 shelters (98%); the
shelter which did not accept owner surrender did accept strays and vice versa. Thirtyseven percent of shelters utilized transport programs for dogs (18/49), and over half of
shelters (34/61) reported housing animals in foster homes, however, shelters were not
asked to distinguish between foster home placement of dogs and cats. Information on the
number of dogs adopted during 2015 was available from 40 shelters. Adoption rate
ranged from 5% to 100% of dogs received, with an average shelter adoption rate of 55%
(Table 2.2).
Table 2.2

Mississippi animal shelter adoption rates for dogs in 2015
Adoption rate
25% and less
25.1% to 50%
50.1% to 75%
Greater than 75%

Shelters Adopting Dogs
6/40 = 15%
12/40 = 30%
11/40 = 27.5%
11/40 = 27.5%

Forty-three shelters provided information on record keeping. Forty-nine percent
of shelters used only paper records, 16% used a shelter database system, 19% used some
other method of record keeping, and 16% used paper records in conjunction with another
type of record. Fifty-four of the 61 shelters identified had a website (89%), and 55 used
social media (90%).
Serum Bank
A total of 571 dogs were sampled from 18 shelters (Figure 2.2). The proportion of
dogs sampled by district ranged from 5.3% (30 dogs) in district 6 to 20.0% (114 dogs) in
district 9 to reflect the distribution of shelter dogs based on the 2015 census (Table 2.1).
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The serum bank included 204 samples from puppies <6 months of age (35.7%). Sporting,
hound, terrier, and herding-type breeds predominated, and most dogs were in good body
condition at the time of sampling (Table 2.3).
Table 2.3

Summary of categorical variables for 571 dogs in the serum bank

Variable Category
Sex Female
Spayed
Male
Neutered male
Not recorded
Age Puppy
2 to 3 months
4 months
5 to 6 months
Adult
0.5 to 1 year
1 to 2 years
2 to 5 years
5 to 10 years
10+ years
Not recorded
Breed Sporting
Hound
Terrier
Herding
Working
Toy
Non-sporting
Not recorded
*Condition Underweight (<4)
(1-9) Normal (4 or 5)
Overweight (>5)

Number
302
80/302
257
66/257
12
204
121/204
49/204
34/204
354
139/354
100/354
98/354
14/354
3/354
13
188
117
104
99
22
9
4
28
34/333
276/333
23/333

%
52.9
(26.5)
45.0
(25.7)
2.1
35.7
(21.2)
(8.6)
(6.0)
62.0
(24.3)
(17.5)
(17.2)
(2.5)
(0.5)
2.3
32.9
20.5
18.2
17.3
3.9
1.6
0.7
4.9
10.2
82.9
6.9

*Body condition data is not available for all dogs and is reflected in the denominator.
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Estimated weight ranged from 3 to 50 lbs for puppies with an average weight of
15 lbs (SD 10.0), and from 10 to 110 lbs for adults with an average weight of 43 lbs (SD
14.1). Physical examination at the time of sample collection revealed a variety of
abnormalities, with coat and skin problems most commonly identified (Figure 2.4). Two
dogs were pregnant, 2 were nursing, and 3 were showing visible signs of estrus at the
time of sample collection.

Figure 2.4

Percent of dogs showing health abnormalities at the time of serum bank
sample collection

Discussion
This paper is the first comprehensive assessment of the Mississippi shelter dog
population. We identified 61 animal shelters in 45 counties in Mississippi, accounting for
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intake of over 56,000 dogs in 2015. Shelters varied widely in size and by adoption rate.
Frequent movement of dogs occurred through foster and transport programs both within
and outside of Mississippi. This report provides a baseline for monitoring future trends in
the Mississippi shelter dog population.14
Information on the location, size, and characteristics of animal shelters is limited
in the United States, and this information is difficult to collect in states where facility
registration is not required. We used three different sources to compile our sampling
frame, including funding sources and internet-based searches. The vast majority of
shelters had a website or social media account, however, this could be a result of
selection bias in our search method. Shelters without an internet presence are very
difficult to find and may have been missed in our attempted census. Additionally, there is
wide variability in the type of organization called an “animal shelter”. We excluded
organizations without a physical facility and those which did not offer public adoptions,
however, often this could only be determined by speaking with a representative of the
organization. Similarly, many support and volunteer groups working with one or more
shelters appeared on our lists and represented duplicate entries. These could be difficult
to identify and verify. Despite our best efforts, our census likely failed to capture some
shelters within the state, especially local animal control offices which offer public
adoption of animals when available.
Much of the information available on animal disease prevalence is based on
convenience sampling rather than random sampling and may not be representative of the
population, especially when disease occurs in clusters.5,15-16 Our serum bank represented
the geographic distribution of dogs across nine regions of the state. By randomly
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sampling dogs within each shelter, we captured a cross-section of the Mississippi shelter
dog population. We used minimal exclusion criteria to reduce selection bias, and believe
the serum bank is a good representative of our target population. However, as with all
samples, potential sources of bias remain and must be identified and accounted for when
the serum bank is applied to a research question.
Shelters were selected for sample collection based on willingness to participate
and previously established relationships, rather than at random. Some shelters were
reluctant to provide detailed information during the phone census and did not wish to
participate in random sampling. Although we have no reason to believe that sampled
shelters differ in meaningful ways from non-sampled shelters, each shelter represents a
unique environment and may differ in disease prevalence. In general, larger shelters were
included in order to collect the required number of samples, however, we sampled from 2
shelters with an annual dog intake below 300, and half of sampled shelters had intake
below 1200.
Although samples were collected over 15 months, we were not sampling by
season. Almost 60% of all samples were collected during the summer, so selection bias
may be present if the dog population housed at shelters differs by season for
characteristics such as age or intake source (stray versus owner surrender). The
proportion of dogs sampled that were puppies (<6 months) did not differ by season, with
the exception of spring. Only two shelters were sampled in the spring, so it is unknown
whether the greater proportion of puppies sampled at those shelters was a result of season
or inherent to the shelters. Similarly, we did not have intake source data on enough dogs
to determine if season was associated with intake source.
76

There is high variability in the daily shelter dog population at many shelters,
which may be reflected in our one-time sample collection at each shelter. For example,
we sampled very few toy breeds for the serum bank. This may represent low intake of
these breeds into animal shelters, or may indicate high demand of these breeds with rapid
adoption. A similar scenario might occur for disease; dogs with clinical signs of illness or
documented infection such as canine heartworm may be less adoptable, have longer
shelter stays, and therefore have a greater likelihood to be sampled compared to healthy
dogs. This might result in increased prevalence within the sampled shelter dog
population.
Despite these limitations, our serum bank is a relatively unique tool for
investigation of disease prevalence, risk factors, and diagnostic test validation.
Knowledge of the Mississippi shelter dog population and distribution obtained through
the state census of shelters allowed us to reduce many potential sources of bias. Our
ultimate goal, accurate measurement of the disease burden in the Mississippi shelter dog
population, is necessary to guide evidence-based public policy regarding zoonotic
diseases and for shelter prioritization of risk management within animal populations.
Impacts of disease in this population are not limited to Mississippi, but may extend across
the United States with the frequent, high volume movement of shelter animals through
transport programs and into homes.

77

Acknowledgements
The authors wish to thank the staff and volunteers at shelters across the state for
their time and ceaseless efforts toward improving the lives of animals. Special thanks to
Liesel Schneider, Min Wang, Dr. Cooper Brookshire, Emily Childers, and Hailey
Deichmann for their help in sample collection. Funding for this study was provided by
the Office of Research and Graduate Studies at Mississippi State University College of
Veterinary Medicine. The authors declare no conflicts of interest.

Footnotes
a. Random.org Random Sequence Generator, Randomness and Integrity Services
Limited, Dublin, Ireland, https://www.random.org/sequences/.
b. Quantum GIS Geographic Information System version 2.14, Open Source
Geospatial Foundation Project, http://qgis.osgeo.org
c. Microsoft Excel version 2013, Microsoft Corporation, Redmond, WA
d. PROC MIXED, SAS, version 9.4, SAS Institute Inc., Cary, NC

78

References
1. Marsh P. Replacing myth with math: Using evidence-based programs to eradicate
shelter overpopulation. Town and Country Reprographics. Available at:
http://shelteroverpopulation.org /Books/Replacing_Myth_with_Math.pdf.
Accessed January 9, 2018.
2. Salman MD, New Jr JC, Scarlett JM, et al. Human and animal factors related to the
relinquishment of dogs and cats in 12 selected animal shelters in the United
States. Journal of Applied Animal Welfare Science 1998;1(3):207-226.
3. Kass PH, New Jr JC, Scarlett JM, et al. Understanding animal companion surplus in
the United States: Relinquishment of nonadoptables to animal shelters for
euthanasia. Journal of Applied Animal Welfare Science 2001;4:237–248.
4. Rowan AN. Shelters and pet overpopulation: A statistical black hole. Anthrozoos
1992;5:140–143.
5. Bowman D, Little SE, Lorentzen L, et al. Prevalence and geographic distribution of
Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma
phagocytophilum in dogs in the United States: Results of a national clinic-based
serologic survey. Veterinary Parasitology 2009;160:138–148.
6. Levy JK, Lappin MR, Glaser AL, et al. Prevalence of infectious diseases in cats and
dogs rescued following Hurricane Katrina. Journal of the American Veterinary
Medical Association 2011;238:311-317.
7. Lovejoy GS, Carver HD, Moseley IK, et al. Serosurvey of dogs for Brucella canis
infection in Memphis, Tennessee. American Journal of Public Health
1976;66:175–176.
8. Brown J, Blue JL, Wooley RE, et al. Brucella canis infectivity rates in stray and pet
dog populations. American Journal of Public Health 1976;66:889–891.
9. Hoff G, Nichols JB. Canine brucellosis in Florida: serologic survey of pound dogs,
animal shelter workers and veterinarians. American Journal of Epidemiology
1974;100:35–39.
10. Duprey ZH, Steurer FJ, Rooney JA, et al. Canine visceral leishmaniasis, United
States and Canada, 2000–2003. Emerging Infectious Diseases 2006;12:440.
11. Bern C, Kjos S, Yabsley MJ, et al. Trypanosoma cruzi and Chagas’ disease in the
United States. Clinical Microbiology Reviews 2011;24:655–681.
12. Macintire DK, Boudreaux MK, West GD, et al. Babesia gibsoni infection among
dogs in the southeastern United States. Journal of the American Veterinary
Medical Association 2002;220:325–329.
79

13. United States Census Bureau. 2015 Population Estimate. Available at:
https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=
bkmk. Accessed August 3, 2017.
14. Lord LK, Wittum TE, Ferketich AK, et al. Demographic trends for animal care and
control agencies in Ohio from 1996 to 2004. Journal of the American Veterinary
Medical Association 2006;229:48–54.
15. Thrusfield M. Chapter 13: Surveys. In: Veterinary Epidemiology. Third Edition.
Blackwell Publishing; 2005.
16. Thurmond MC, Blanchard PC, Anderson ML. An example of selection bias in
submissions of aborted bovine fetuses to a diagnostic laboratory. Journal of
Veterinary Diagnostic Investigation 1994;6:269–271.

80

CHAPTER III
SEROPREVALENCE OF BRUCELLOSIS IN MISSISSIPPI SHELTER DOGS
(Prepared for submission to Preventive Veterinary Medicine)

Kristina J. Hubbard, Min Wang, and David R. Smith

Department of Pathobiology and Population Medicine, College of Veterinary Medicine,
Mississippi State University, 240 Wise Center Drive, Mississippi State, MS, USA

81

Abstract
Canine brucellosis is an emerging disease and compatible with a One Health
management approach. Previous research has found higher Brucella canis seroprevalence
in stray dog populations than in owned animals, and shelter dogs may represent a
zoonotic risk to pet owners. Dogs may also contract other Brucella spp., including
Brucella suis, which is carried by some feral swine in the United States and poses a
public health risk.
Diagnostic tests for Brucella spp. are imperfect. Misclassification of disease status
can result in serious repercussions for canine and human health including the unnecessary
euthanasia of falsely positive dogs or failure to identify and remove falsely negative dogs
from susceptible populations. Correct interpretation of any diagnostic test requires
knowledge of the pre-test probability of disease in the population, therefore the objective
of this study was to estimate the seroprevalence of B. canis and B. suis in Mississippi
shelter dogs to guide evidence-based diagnostic testing and inform policy
recommendations.
Banked serum samples from 571 dogs collected in 2016-2017 as a representative
sample of the Mississippi shelter dog population were tested for B. canis using a
commercial rapid slide agglutination test (RSAT) and for B. suis using a buffered
acidified plate agglutination test. No dogs were seropositive for B. suis antibodies.
Twenty-eight dogs (4.9%) were seropositive for B. canis antibodies on the RSAT, with
13 dogs (2.3%) remaining positive when retested with the addition of 2-mercaptoethanol
to increase specificity. Test prevalence by shelter ranged from 0 to 8.6%. True prevalence
was estimated using stochastic modeling to account for test performance and clustering of
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dogs by shelter. Approximately 65% of modeled shelters did not have seropositive dogs.
For shelters where B. canis was present, the mean modeled seroprevalence was 17.8%.
This study reveals important information regarding the distribution of B. canis
seroprevalence in Mississippi shelter dogs. Current diagnostic tests lack the sensitivity
needed to correctly identify individual infected dogs, but population testing may provide
a reasonable estimate of disease. Eradication or control measures should focus on the
small number of shelters where canine brucellosis occurs to effectively minimize
transmission among dogs and to humans.

Keywords: Canine brucellosis, seroprevalence, animal shelter
Abbreviations:
BAPA: Buffered acidified plate agglutination
LPS: lipopolysaccharide
NVSL: National Veterinary Services Laboratory
RSAT: Rapid slide agglutination test
2ME-RSAT: 2-mercaptoethanol rapid slide agglutination test
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Introduction
Brucellosis is a global animal disease with significant zoonotic potential and an
ideal example of the importance of the One Health initiative because of the interface
between wildlife, domestic animal, and human populations. Brucella spp. are classically
identified by their natural host species, with dogs serving as the natural host for B. canis.
Domestic dogs can be infected with three additional Brucella spp.: B. suis, B. abortus,
and B. melitensis, typically following exposure to swine, cattle, and small ruminants,
respectively.1
A recent serosurvey in Georgia found 1.3% of dogs seropositive for B. suis, with
speculated transmission occurring through recreational hunting of feral swine.2
Additionally, B. canis infection in dogs became reportable in Mississippi in 2016,
following a human case linked to a stray dog.3 These previously under-recognized
zoonotic risks have created a need for veterinary practitioner education on appropriate
testing strategies and interpretation, which is dependent on the prevalence of disease in
the dog population.
In the United States, a higher prevalence of B. canis has been reported in stray
and free-roaming dogs, particularly in the rural southeast.4-5 This subset of the dog
population has a greater proportion of reproductively intact dogs compared to owned
dogs, facilitating transmission through reproductive contact.6 Stray dogs may also have
increased exposure to and predation of wildlife, which can serve as a source of
brucellosis infection.7 Free ranging feral swine, present in at least 39 states including
Mississippi, remain a recognized source for B. suis.8 Seroprevalences of 0.3 to 52.6%
have been reported in feral swine, varying with geographic region, season, and animal
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factors.9 Transmission of B. suis to domestic swine, dogs, cattle, and people has been
demonstrated in the United States, with feral swine serving as an important source for
introduction of the disease into atypical host species. 2,8,10-13
Diagnosis of brucellosis is complicated by vague or absent clinical signs and
imperfect tests. Common human and livestock serological screening tests detect
antibodies against the lipopolysaccharide (LPS) component of the outer cell membrane.
These tests do not differentiate B. abortus, B. melitensis, and B. suis, all of which
typically form smooth phenotype colonies and contain complete LPS molecules. Rough
colony forming species, including B. canis, lack the LPS O-side chain and do not crossreact with smooth species.1 Instead, a commercial rapid slide agglutination test (RSAT) is
available for in-house B. canis testing. Samples showing agglutination are retested with
the addition of 2-mercaptoethanol to improve test specificity, but may fail to detect some
positives.14 To detect other Brucella spp., dogs may be tested using smooth-strain antigen
such as that employed in the buffered acidified plate antigen (BAPA) test recommended
by the OIE for B. suis screening of livestock and wildlife.15
Considering these diagnostic challenges, identifying infected animals is difficult.
Shelter dogs may serve as a bridging population, bringing potentially infected dogs into
intimate contact with human family members. This poses an unquantified risk for human
health, especially for the 20% of the population most immunologically susceptible,
including children and the elderly, for whom shelter animals often provide
companionship.16 The zoonotic potential of B. canis is well recognized, though human
cases are rare.5,17 Brucella suis has greater zoonotic potential than B. canis, dependent on
biovar and host, with urine and saliva speculated as vehicles for the transmission of B.
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suis from dogs to humans.18 Isolated cases of natural infection of dogs with B. suis have
been documented,2,19-20 but no additional information is known on prevalence of the
disease in dog populations. Mississippi has a large feral swine population with potential
transmission of B. suis to dogs through predation of feral swine or birthing materials,
especially dogs used for feral swine hunting or free-ranging dogs which may enter
shelters as strays.2,8
In addition to posing a local zoonotic risk, undiagnosed dogs may also contribute
to spread of brucellosis from areas of higher endemicity to new populations. Shelter dogs
are highly mobile both within the state of Mississippi as well as nationally through foster
networks and transport programs, which move animals from overcrowded shelters to
adoption centers where animals are in greater demand. Animals are typically screened for
visible signs of disease, but a comprehensive diagnostic workup is usually not performed
due to financial limitations and lack of requirements for such testing before interstate
movement. Infected dogs moved to historically low-risk areas may be more likely to
remain in the population if clinicians have a low index of suspicion for the disease, even
in dogs showing consistent clinical signs. Infected dogs may serve as a source of Brucella
spp. for other animals and people during the bacteremic phase which may exceed two
years.21
A stray dog seropositive for B. canis was identified during a 1976 survey of a
single Mississippi site,22 however, to date, no systematic sampling of Mississippi dogs
has been performed to identify if, and to what extent, B. canis and B. suis are present in
this population. Therefore, the objective of our study was to estimate the seroprevalence
of these pathogens to guide evidence-based risk assessment and public policy.
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Materials and Methods
A cross-sectional study was performed on samples collected from shelter dogs
across Mississippi between 2016 and 2017 as a representative serum bank (Chapter 2). In
brief, dogs were proportionately sampled from one, two, or three shelters within each of
the nine state public health districts to reflect the geographic distribution of dogs across
the state, determined from a statewide census of animal shelters. Whole blood samples
were collected from 571 randomly sampled dogs over 8 weeks of age from 18
participating shelters. Serum was separated and stored at -80°C until testing. A sample
size of ~500 dogs was selected to provide precision of 0.03 when using the 2ME-RSAT
(sensitivity 0.32, specificity 1),14 an expected true prevalence of 0.04, and a confidence
level of 0.95.23
B. canis testing
Serum samples were tested for the presence of B. canis antibodies using a
commercially available RSAT (D-TEC® CB, Synbiotics) according to kit instructions.
Samples with visible agglutination were retested with the addition of 2-mercaptoethanol
(2ME-RSAT) to remove nonspecific agglutinins and improve test specificity.21 Dogs
were considered positive for B. canis if both the RSAT and the 2ME-RSAT showed
visible agglutination.
B. suis testing
A BAPA test was performed using B. abortus antigen according to the procedure
obtained from the National Veterinary Services Laboratory (NVSL) to detect B. suis or
other smooth Brucella spp.24 Positive and negative B. suis controls from the NVSL were
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run on each plate, and a sample was considered positive if it showed macroscopic
agglutination similar to the positive control.
Data analysis and stochastic modeling
B. canis apparent seroprevalence was calculated as the proportion of 2ME-RSAT
test positive dogs out of total tested dogs. Descriptive statistics, including apparent
prevalence by district, shelter, and several dog characteristics, were performed using a
commercial spreadsheet program.a Risk factors for 2ME-RSAT seroprevalence were
assessed using manual forward selection in multivariable logistic regression, with shelter
included as a random effect in all models.b Age was recorded as a categorical variable but
analyzed as a binomial variable (dogs ≤2 years of age versus dogs >2 years of age) due to
low accuracy of age estimation in older dogs. Sex was recorded as intact female, spayed
female, intact male, or neutered male, but intact and altered animals were grouped for
each sex for analysis since spayed female dogs could not be reliably identified and we
were unable to determine temporal relationships between time of sterilization, entry into
shelter, and seroconversion. Shelter source, when available, included animals surrendered
by owner and stray animals (including intake through animal control services). Breed
group was categorized by predominant breed identified during physical exam and further
consolidated by dog size and historical breed purpose (e.g. hunting-type breeds). Due to
the expected low prevalence of B. canis, significance was defined a priori at α=0.1.
To account for imperfect test performance and clustering by shelter, true
prevalence was estimated using stochastic models.c Binomial parametric distributions
were used for input variables and included two parameters: total samples tested and
probability of a positive test derived from the number of test positive animals (Table 3.1).
88

The distributions for test sensitivity and specificity were defined from literature reports of
2ME-RSAT performance.14 The distribution of prevalence by shelter was defined using
total dogs sampled at each of 18 shelters and the corresponding apparent prevalence by
shelter.
Convergence tolerance was set at 1% (with a 95% confidence interval), and Latin
hypercube sampling with 5,000 iterations was conducted to meet the convergence criteria
(i.e. the change in the median of main outputs converged at 1.0% or less). Outputs
included test sensitivity, test specificity, apparent prevalence for each of 18 shelters, and
total apparent prevalence over all shelters (Table 3.2). Overall true prevalence and true
prevalence for each of the 18 modeled shelters was calculated for each of the 5,000
iterations as:
𝑃 𝑇 +𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦−1

P = 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦+𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦−1

(3.1)

where PT is the test, or apparent, prevalence,23 and 2ME-RSAT specificity and sensitivity
are 100% and 31.76%, respectively.14
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Table 3.1

Model parameters, number seropositive (m), number sampled (n),
prevalence (p), commands and distributions

Parameter

m

n

p

Command and distribution

*2ME-RSAT Sensitivity

27

85

0.3176

RiskBinomial(85,0.3176)

*2ME-RSAT Specificity

42

42

1

RiskBinomial(42,1)

Shelter 1

0

32

0.0000

RiskBinomial(32,0)

Shelter 2

0

12

0.0000

RiskBinomial(12,0)

Shelter 3

1

29

0.0345

RiskBinomial(29,0.0345)

Shelter 4

0

13

0.0000

RiskBinomial(13,0)

Shelter 5

1

29

0.0345

RiskBinomial(29,0.0345)

Shelter 6

1

26

0.0385

RiskBinomial(26,0.0385)

Shelter 7

0

12

0.0000

RiskBinomial(12,0)

Shelter 8

0

16

0.0000

RiskBinomial(16,0)

Shelter 9

0

52

0.0000

RiskBinomial(52,0)

Shelter 10

0

18

0.0000

RiskBinomial(18,0)

Shelter 11

0

21

0.0000

RiskBinomial(21,0)

Shelter 12

3

95

0.0316

RiskBinomial(95,0.0316)

Shelter 13

1

27

0.0370

RiskBinomial(27,0.0370)

Shelter 14

1

58

0.0172

RiskBinomial(58,0.0172)

Shelter 15

1

31

0.0323

RiskBinomial(31,0.0323)

Shelter 16

1

25

0.0400

RiskBinomial(25,0.0400)

Shelter 17

3

35

0.0857

RiskBinomial(35,0.0857)

Shelter 18

0

40

0.0000

RiskBinomial(40,0)

*Data from Keid et al.14
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Table 3.2

Model simulated values and final outputs

Simulated values

2ME-RSAT sensitivity: number positive (m) from
RiskBinomial(85,0.3176)/85
2ME-RSAT specificity: m from RiskBinomial(42,1)/42
Shelter B. canis: m1-18 from RiskBinomial for each of 18 shelters

Model 1 Outputs:

Total number seropositive: ∑(m1…m18)

Overall Prevalence

Apparent prevalence: ∑(m1…m18)/571
True prevalence:
Frequency distribution (Figure 3.1) shows true prevalence from
5,000 iterations of total number seropositive

Model 2 Outputs:

Apparent prevalence: Simulated (m)/n for each of 18 shelters

Prevalence by Shelter

True prevalence: calculated as above for each of 18 shelters
Frequency distribution (Figure 3.2) shows true prevalence by
shelter from 5,000 iterations each of 18 shelters (90,000
simulated shelters)

Results
Serum samples from 571 dogs were tested for the presence of brucellosis
antibodies. No animals were seropositive for B. suis on the BAPA. Twenty-eight samples
(4.9%) were initially positive for B. canis on the RSAT. Thirteen samples remained
positive on the 2ME-RSAT for an apparent prevalence of 2.3% in this population.
Apparent prevalence by district ranged from 0 to 6.3%, and apparent prevalence by
shelter ranged from 0 to 8.6% (Table 3.3). Of the 18 sampled shelters, 9 shelters had no
dogs positive for brucellosis, 7 shelters had a single positive dog, and the remaining 2
shelters each had 3 seropositive dogs.
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Table 3.3

Apparent prevalence of B. canis by geographic district and individual
shelter using the 2ME-RSAT
Shelter 1

District

No.
sampled

B. canis pos
(%Prev)

1
2
3
4
5
6
7
8
9
Total

57
64
33
56
108
30
32
77
114
571

2 (3.5)
4 (6.3)
0 (0)
2 (3.6)
3 (2.8)
0 (0)
0 (0)
1 (1.3)
1 (0.9)
13

n

B. canis pos
(% Prev)

26
35
21
29
95
18
32
25
58

1 (3.8)
3 (8.6)
0 (0)
1 (3.4)
3 (3.2)
0 (0)
0 (0)
1 (4.0)
1 (1.7)

Shelter 2

Shelter 3

n

B. canis pos
(% Prev)

n

B. canis pos
(% Prev)

31
29
12
27
13
12
52
40

1 (3.2)
1 (3.4)
0 (0)
1 (3.7)
0 (0)
0 (0)
0 (0)
0 (0)

16

0 (0)

Sex, source, and breed were not associated with odds for being B. canis
seropositive, however, age was significant (Table 3.4). Adult dogs had 14.4 times greater
odds for being seropositive compared to puppies (95% CI: 1.81, 114.24). All 13 positive
samples came from adult dogs, for an apparent prevalence of 3.6% in this population.
Multivariable logistic regression using manual forward selection did not improve model
fit or identify other significant risk factors.
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Table 3.4
Variable

Age
Sex
Source
Breed

Logistic regression analysis of individual dog risk factors for B. canis
Levels

n

B. canis pos
(%Prev)

p

OR

Lower
95% CI

Upper
95% CI

>2 years
≤2 years
Male
Female
Owner Surrender
Stray
Terrier/Toy
Herding/Working/
Non-sporting
Hound
Sporting

155
443
255
298
49
68
113
125

6 (5.2)
7 (1.6)
8 (3.1)
5 (1.7)
3 (6.1)
1 (1.5)
5 (4.4)
4 (3.2)

0.03
Ref
0.27
Ref
0.19
Ref
0.08
0.20

3.43

1.13

10.43

1.90

0.61

5.89

5.07

0.45

56.53

4.37
3.10

0.83
0.56

23.06
17.26

117
188

1 (0.9)
2 (1.1)

0.87
Ref

0.81

0.07

9.12

Not all information was available for every dog. Models contain the following number of
observations: age (n=558), sex (n=553), source (n=117), breed (n=543). Shelter included
as a random effect in all models (PROC GLIMMIX).
Stochastic modeling of B. canis true prevalence within the Mississippi shelter dog
population resulted in a distribution exhibiting right skew with a mean of 7.4% and a
95% credible interval of 3.5% to 12.8% (Figure 3.1). However, the model produced a
bimodal distribution of B. canis seroprevalence by shelter with no B. canis present in
64.6% of shelter iterations. Of the remaining 35.4% of shelters, mean seroprevalence in a
shelter was 17.8%. Seroprevalence by shelter exhibited right skew, with a median
seroprevalence of 13.3% (Figure 3.2).
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Figure 3.1

Modeled true prevalence of B. canis in the Mississippi shelter dog
population

Stochastic model includes 5,000 iterations. The shaded portion represents the 95%
credible interval.
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Figure 3.2

Modeled true seroprevalence of B. canis by shelter

Modeled are 5,000 iterations for each of 18 sampled shelters. The box and whisker plot
denotes the minimum, first quartile, median, third quartile, and 99th percentile for the
35.4% of shelters with B. canis. The maximum modeled value, prevalence of 1.0, is not
shown to improve graph clarity.
Discussion
Our seroprevalence estimates are consistent with previous reports of brucellosis in
shelter dog populations. Although we did not detect B. suis, we expected very low
prevalence in the state and did not selectively sample hunting dogs which have the
greatest risk of exposure.2 Rather, we were able to confirm that shelter dogs do not pose a
meaningful B. suis zoonotic risk. The apparent B. canis prevalence of 2.3% in this study
is similar to other findings, with the slightly lower prevalence likely due to differences in
serological tests used and sampling strategy. We included puppies in our testing because
infection can result from exposure during whelping or nursing from an infected bitch,
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however, all positive dogs in our sample were adults which we expect to be at greatest
risk due to predominately venereal transmission of B. canis.5 Apparent prevalence in
adult dogs sampled was 3.6%.
Previous studies have not reported prevalence corrected for imperfect diagnostic
test performance. Challenges in serologic diagnosis of brucellosis are well
recognized,21,25-26 and the commercial RSAT has poor diagnostic sensitivity when used in
series with the 2ME-RSAT.14 Reports of apparent prevalence are therefore likely to
underestimate true prevalence of B. canis. Calculations for true prevalence are
straightforward and should be applied when assessing disease risk, however, more
advanced statistical methods, such as stochastic modeling, may be needed to determine a
confidence interval around the true prevalence when accounting for clustering or other
effects of sampling strategy.
The mean seroprevalence we obtained from our model of overall prevalence is
similar to that expected when correcting for test performance. Our model produced a
narrower 95% credible interval than the corresponding 95% confidence interval of true
prevalence calculated by the standard, but conservative, equation using the normal
approximation.23 More importantly, the bimodal distribution from our stochastic model
by shelter indicates that B. canis prevalence in our target population is not adequately
described by a singular mean value. Mississippi animal shelters do not have an “average”
prevalence of brucellosis, rather, the majority of shelters do not have B. canis, while a
small number have a much greater prevalence of disease.
Additional work is necessary to determine if these disease clusters result from our
sampling process, increased transmission of brucellosis in some shelters, or differing
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levels of brucellosis in communities surrounding shelters. Shelter seroprevalence was
measured on a single sampling day and may not be repeatable or reflective of an
individual shelter or community. However, if certain shelters consistently contain
seropositive dogs, eradication or control efforts may be most effective when resources are
allocated to identify and minimize disease at the individual shelter level. Interventions for
shelters with brucellosis may include management practices, such as eliminating group
housing of intact dogs if transmission occurs within the shelter, or community education
and policy concerning owned and stray dogs if dogs are already seropositive at shelter
intake.
Currently available diagnostic tests misclassify some individual dogs. The most
likely outcome for test positive dogs in a shelter is euthanasia, so a highly specific test is
desirable to prevent false positives. Use of the 2ME-RSAT test to diagnose positive dogs
improves test specificity, but results in decreased test sensitivity and a greater proportion
of false negatives which remain in the population. Based on our stochastically estimated
population prevalence of 7.4%, removal of 2ME-RSAT test positives results in an
absolute risk reduction of 2.2% and requires 44 dogs to be tested to identify a positive.
Assuming a cost of $26.00 per test, the cost to identify a positive dog is ~$1150, a
considerable investment for animal shelters which are often resource poor, especially
considering that 5% of dogs in the population remain positive.
Effective brucellosis control cannot be achieved by individual dog testing,
however, population testing may be useful to estimate if brucellosis is present in
individual shelters. Our model demonstrates that most shelters should not be prioritizing
limited resources toward brucellosis control, but a small number of shelters may have a
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high seroprevalence of brucellosis that could pose a risk for transmission to other dogs,
shelter workers, or adopters. Similar to breeding kennels, identification of these high-risk
shelters depends on recognition of clinical signs or requires population testing at several
time points, with limited risk reduction and high cost. Other preventive measures, such as
spay/neuter of all dogs prior to adoption and public education including clinical signs of
disease and good hygiene practices, may feasibly reduce transmission risk to other dogs
and to humans and be more viable options for brucellosis control in animal shelters.
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b. PROC MIXED, SAS, version 9.4, SAS Institute Inc., Cary, NC
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Abstract
American trypanosomiasis, caused by the parasite Trypanosoma cruzi, is
uncommon in the United States, but may result in serious cardiac disease in infected
people and animals. Domestic dogs are important hosts in domestic cycles in South
America, and naturally occurring canine cases have been reported in the United States.
Triatomine insects, the primary biological vector, are present across the southern United
States and endemic disease has been described in wildlife. Dogs may be a useful sentinel
for human disease risk due to similarities in disease between the two species. Freeranging dogs or those housed primarily outside may have greater exposure to feeding
vectors and through ingestion of infected insects.
A serum bank containing samples from 566 shelter dogs proportionately sampled
from nine geographic districts in Mississippi was tested for the presence of T. cruzi
antibodies using a commercial immunochromatographic assay validated for use in
domestic dogs. Forty-two of 566 dogs were seropositive for T. cruzi (7.4%, 95% CI: 4.7,
10.1%). Prevalence by shelter ranged from 0 to 25%, but neither shelter nor district was
significantly associated with the probability of being seropositive. Although 6 puppies <6
months of age were seropositive for T. cruzi, adult dogs had 3.6 times greater odds for
being seropositive. Accounting for the random effect of shelter, the greatest modeladjusted T. cruzi seroprevelance by age was seen in dogs 3-5 years of age (p̂=0.17,
SE=0.05). Other risk factors including sex, breed, and source were not significant in
logistic regression models containing shelter as a random effect.
This is the first report of the prevalence of T. cruzi in the Mississippi dog
population. Shelter dogs may serve as useful sentinels and provide an initial estimate of
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typanosomiasis occurrence and distribution within the state. These data help us assess the
risk for dogs to be infected with T. cruzi as well as the public health risk posed by T.
cruzi in Mississippi.

Keywords: American trypanosomiasis, Chagas’ disease, shelter dogs
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Introduction
Chagas’ disease is classified as one of five neglected parasitic diseases by the
Centers for Disease Control and Prevention due to the limited surveillance and prevention
measures currently in place.1 People and dogs show very similar courses of disease when
infected with Trypanosoma cruzi, with the exception of frequent sudden death due to
cardiomyopathy seen in dogs less than 1 year of age. In older dogs and people, the
disease is often asymptomatic in acute cases, although severe disease may rarely result in
myocarditis or encephalitis.2
Chronic infections result in severe cardiac or gastrointestinal disease in 20-30% of
people,3 while over 80% of experimentally infected dogs showed abnormal
electrocardiograms (ECGs) three months after disease induction.4 Treatment options are
limited and carry a high complication rate, contributing to the large economic burden of
the disease in endemic areas.2,5 Although autochthonous human cases are rare in the
United States, implementation of blood donor screening has increased identification of
chronic carriers.6 Since screening begin in 2007, two Mississippi donors have been
identified with suspect locally-acquired infections.7
T. cruzi is endemic in much of the southern United States, and the disease can be
carried by over 100 animal species. Raccoons and opossums have the highest reported
prevalence, ranging from 1.5-63% and 8-33% respectively.8 Transmission occurs
primarily through the bite of triatomine bugs, commonly called kissing bugs, 11 species
of which are found in the United States. Triatoma sanguisuga is broadly distributed
across the entire Southeast, including Mississippi, and has a wide host range including
wildlife, dogs, chickens, and humans.2
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Dogs are recognized hosts for Chagas’ disease in South and Central America, and
local transmission to dogs has been reported in the United States.9-11 Dogs may acquire
the infection through ingestion or from the bite of an infected triatomine insect, and may
pose a zoonotic risk by serving as a source of infection for other triatomine insects or
through direct contact with an infected dog’s blood such as by an accidental needlestick.10 Dogs may also serve as a sentinel for human disease, as they often have greater
exposure to infectious vectors and they have a shorter incubation time with clinical
manifestations recognized in domestic dogs before identification of disease in humans.9-10
Prevalence of T. cruzi is poorly documented for dogs in the United States.
Although several studies have reported population level prevalence, studies vary widely
in the population tested and diagnostic test(s) used, making comparisons across studies
difficult. 10,12-17 In addition, several previous reports have used convenience sampling
which may not be indicative of the overall dog population. Studies may also suffer from
lack of resolution; vector borne diseases such as Chagas’ may occur at uneven rates, with
pockets of hyperendemicity occurring with convergence of suitable vector habits, high
populations of reservoir hosts, and higher rates of disease and transmission.18 Systematic,
intensive sampling may be required to detect important differences in regional
transmission and dog risk factors for disease.
No studies have measured seroprevalence in Mississippi dogs, and limited
information is available on occurrence in wildlife and triatomine vectors.2 There have
been comparatively few human Chagas’ cases in Mississippi found during blood
donation screening, with only 9 of the 2281 confirmed positives in the AABB
Biovigilance Network reported from Mississippi in the past 10 years.19 However, these
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low numbers are likely reflective of a smaller Latin America immigrant population in
which the majority of positives are measured. Of note, two Mississippi natives were
identified as probable autochthonous cases shortly after widespread blood donor
screening was implemented, and triggered The United States Trypanosoma cruzi
Infection Study by the CDC.6 Human cases in Mississippi may therefore represent greater
occurrence of indigenously acquired disease than many other states. Stratified random
testing of shelter dogs on a state-wide level may help resolve important questions on T.
cruzi prevalence in Mississippi as an indication of autochotonous disease risk for both
dogs and humans.
Materials and Methods
Serum samples were banked from a cross-sectional study of shelter dogs across
Mississippi (Chapter 2). In brief, samples were obtained following a census of animal
shelters within the state of Mississippi to determine shelter dog population and
distribution. A total of 571 dogs were proportionately sampled from the nine Public
Health Districts within the state to represent geographical population distribution. In each
district, 1-3 shelters were sampled based on previously established relationships and
willingness to participate. Each dog in the shelter over 8 weeks of age was assigned a
consecutive number, and dogs selected for sampling were chosen via a random number
generator. Whole blood samples, not exceeding 10% of the dog’s circulating blood
volume, were collected, kept on ice during transportation then refrigerated until
processing within 24 hours of sampling. Blood tubes were centrifuged at 3000 rpm for 10
minutes, followed by serum collection using a pipette. Sera was banked in 1.0ml aliquots
at -80°C. Each sample was labeled with an identification number, dog name or number
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assigned by the shelter, collection date, and shelter of origin. Brief physical exam
information for each sampled dog was recorded in a database, along with quantity of
serum banked and any test results obtained on serum samples.
Available banked serum samples (n=566) were tested for the presence of T. cruzi
antibodies using a commercial immunochromatographic assay (Chagas’ STAT-PAK,
Chembio Diagnostic Systems, Inc., Medford, NY, USA) designed for human blood
screening but validated for use in domestic dogs.16 Apparent T. cruzi seroprevalence and
95 percent confidence interval accounting for clustering by shelter was calculated for the
Mississippi shelter dog population based on the results of the immunochromatographic
test.20 Apparent seroprevalence for each of 18 sampled shelters was mapped using open
source geographic information system software.a
The association between seropositive status and various dog characteristics was
tested using logistic regression models.b Candidate categorical variables included
geographic region (1-9), shelter (1-18), sex (male or female), intake source (owner
surrender or stray/animal control), and breed (primary identified breed classified into the
7 American Kennel Club breed groups and further consolidated into 4 groups due to low
numbers of toy, non-sporting, and working group dogs sampled). Age was analyzed as a
binary variable (puppies <6 months of age or adults >6 months of age based on eruption
of secondary canine teeth) to investigate the probability of dogs less than 6 months of age
being seropositive, a population which has rarely been included in previous serosurveys.
Additionally, association between seropositive status and age was analyzed for young
dogs (<2 years of age) and mature dogs (>2 years of age), as in a previous study; separate
models were prepared for all dogs tested in the serum bank and with the removal of
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puppies less than 6 months of age.17 Finally, age was analyzed as a categorical variable
with 4 levels based on researchers’ confidence in estimating dog age (<6 months, 6
months to 2 years, 3-5 years, >5 years of age), and displayed as the model-adjusted
prevalence by age. Shelter was included as a random effect in all univariable models and
in multivariable model assessment using manual forward selection. Because of an
expected low prevalence, an alpha of 0.1 was selected a priori for assessing risk factors.
Results
Forty-two of 566 dogs tested positive for antibodies to T. cruzi, for an apparent
prevalence of 7.4% (95% CI: 4.7, 10.1%) in the Mississippi shelter dog population.
Prevalence by shelter ranged from 0 to 25%, but was not associated with geographic
district (Figure 4.1). Risk factors including shelter of origin, sex, breed group, and source
were not significant (Table 4.1). However, adult dogs (>6 months of age) had 3.60 times
greater odds for being seropositive than puppies (95% CI: 1.49, 8.73). Dogs >2 years of
age had 2.98 times greater odds for being seropositive than dogs <2 years of age (95%
CI: 1.51, 5.88), which remained significant with the removal of puppies less than 6
months of age (OR=2.68, 95% CI: 1.23, 5.86; Table 4.2). Age was significant when
assessed as a categorical variable, with higher T. cruzi seroprevalence in dogs between 35 years of age than in dogs <6 months or between 6 months and 2 years (Figure 4.2).
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Figure 4.1

Seroprevalence of T. cruzi in 566 sampled dogs from 18 shelters

*Represents two shelters sampled in a single county, with no positive dogs sampled in
either. Roman numerals depict the nine public health districts in Mississippi.
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Table 4.1

Prevalence of T. cruzi in sampled dogs and univariable analyses of risk
factors for seroprevalence

Risk Factor
District
Intercept
I – Northwest
II – Northeast
III – Delta Hills
IV – Tombigbee
V – West Central
VI – East Central
VII – Southwest
VIII – Southeast
IX – Coastal Plains
Shelter
Intercept
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
*Sex
INTERCEPT
Female
Male
*Breed
INTERCEPT
Sporting
Hound
Herding/Working
Terrier/Toy/Nonsporting
*Source
INTERCEPT
Owner Surrender
Stray/Animal Control

n

No. pos
(%)

OR

95% CI

Estimate

SE
0.43
0.63
0.61
0.74
0.60
438.1
1.10
0.73
0.53

p
0.73
<.0001
0.78
0.78
0.79
Ref
0.22
0.98
0.23
0.14
0.94
0.63
<.0001
0.99
0.27
0.79
0.99
0.12
0.97
0.43
0.85
0.15
0.16
0.99
0.99
0.34
0.59
0.99
0.64
0.53
Ref
0.48
<.0001
0.46
Ref
0.71

54
64
33
55
108
30
32
76
114

5 (9.3)
6 (9.4)
3 (9.1)
6 (10.9)
6 (5.6)
0 (0)
1 (3.1)
3 (3.9)
12 (10.5)

0.83
0.85
0.82
Ref
0.48
<.001
0.26
0.34
0.96

0.24-2.92
0.26-2.80
0.19-3.52
Ref
0.15-1.57
<.0010.03-2.31
0.08-1.41
0.34-2.72

-2.10
-0.18
-0.17
-0.20
0
-0.73
-13.47
-1.33
-1.09
-0.04

24
30
29
35
12
21
28
27
13
95
12
18
32
51
25
16
40
58

0 (0)
5 (16.7)
3 (10.3)
3 (8.6)
3 (25.0)
0 (0)
4 (14.3)
2 (7.4)
3 (23.1)
3 (3.2)
0 (0)
0 (0)
1 (3.1)
3 (5.9)
0 (0)
2 (12.5)
5 (12.5)
5 (8.6)

<.001
2.12
1.22
0.99
3.53
<.001
1.77
0.85
3.18
0.35
<.001
<.001
0.34
0.66
<.001
1.51
1.51
Ref

<.0010.56-8.02
0.27-5.54
0.22-4.46
0.71-17.5
<.0010.43-7.19
0.15-4.69
0.65-15.5
0.08-1.51
<.001<.0010.04-3.10
0.15-2.93
<.0010.26-8.68
0.41-5.63
Ref

-2.36
-14.21
0.75
0.20
-0.006
1.26
-14.21
0.57
-0.16
1.16
-1.06
-14.21
-14.21
-1.07
-0.41
-14.21
0.41
0.41
0

0.47
807.5
0.68
0.77
0.76
0.81
863.3
0.71
0.87
0.81
0.75
1142.1
932.5
1.12
0.76
791.2
0.89
0.67
Ref

275
238

25 (8.3)
17 (6.7)

1.27
Ref

0.67-2.42
Ref

-2.62
0.23
Ref

0.28
0.33
Ref

187
116
120
115

11 (5.9)
10 (8.6)
9 (7.5)
10 (8.7)

Ref
1.59
1.21
1.52

Ref
0.66-3.79
0.47-3.10
0.63-3.72

-2.76
Ref
0.50
0.18
0.38

0.35
Ref
0.45
0.49
0.46

Ref
0.30
0.69
0.35

0.46-7.23
Ref

-2.77
0.60
Ref

0.52
0.70
Ref

0.39
0.006
0.39
Ref

49
68

5 (10.2)
4 (5.9)

1.82
Ref

*Univariable models include shelter as a random effect.
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Table 4.2

Univariable analyses for T. cruzi seroprevalence association with age

Risk Factor
Age 1
Intercept
Puppy (<6 months)
Adult (>6 months)
Age 2
Intercept
Young (<2 years)
Adult (>2 years)
Age 3
Intercept
Young (<2 yrs, no
pups)
Adult (>2 years)
Age 4
Intercept
1 (<6 months)
2 (6m-2yr)
3 (3-5 yrs)
4 (5+ yrs)

n
564

No. pos (%)

OR

95% CI

Estimate

SE

202
362
553

6 (3.0)
36 (9.9)

Ref
3.59

Ref
1.47-8.77

-3.46
Ref
1.28

0.43
Ref
0.45

439
114
333

24 (5.5)
16 (14.0)

Ref
2.98

Ref
1.51-5.88

-2.87
0
1.09

0.26
0.35

219

13 (5.9)

Ref

Ref

-2.77
0

0.31
-

114
553

16 (14.0)

2.68

1.23-5.86

0.99

0.40

220
219
78
36

11 (5.0)
13 (5.9)
13 (16.7)
3 (8.3)

Ref
1.14
3.87
1.81

Ref
0.49-2.66
1.63-9.20
0.47-6.91

-2.94
0
0.13
1.35
0.59

0.34
0.43
0.44
0.68

Shelter is included as a random effect in all models.

Figure 4.2

Model-adjusted T. cruzi seroprevalence by dog age

Different superscripts represent significant differences in probability for T. cruzi
seropositivity by age at α=0.1. Error bars represent one standard error.
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p
0.005
<.001
Ref
0.005
0.002
Ref
0.002
0.014
Ref
0.014
0.009
<.001
Ref
0.75
0.002
0.39

Discussion
This study provides the first estimate of the probability for dogs being
seropositive for T. cruzi in Mississippi. We found an apparent seroprevalence of 7.4% in
Mississippi shelter dogs, consistent with findings from a similar study reporting 8.8%
seroprevalence in Texas shelter dogs.17 Other research has detected a lower
seroprevalence of 2.3% in Louisiana shelter dogs,13 and prevalence rates between 2.6%
and 12% in owned dogs from southern states.10,12,14-16 This variation may reflect
differences in disease endemnicity rates, exposure risks between owned and shelter dog
populations, or diagnostic test performance.
Seropositive shelter dogs were found in 8 of 9 geographic districts in the state,
and in 13 of 18 sampled shelters, indicating widespread exposure to infectious insect
vectors or mammalian hosts. Additionally, geographic districts showed wide variation in
seroprevelance between shelters. Reasons for these differences may include focal pockets
with higher disease occurrence, transmission within a shelter, or may be an artefact of our
sampling strategy. Samples were collected from each shelter on a single day, and
seroprevalence at the individual shelter level may not be a consistent and repeatable
measure.
Age was significantly associated with the probability of being seropositive in our
study. Infection with T. cruzi has been detected in dogs as young as 6 weeks of age,21
however, little work has been done to measure disease in dogs less than 6 months of age.
Young dogs (<1 year) are at increased risk for sudden death or severe signs of disease,11
but our study also indicates a low prevalence of subclinical infection. Odds for being
seropositive were 3.6 times greater in dogs >6 months of age, and the model-adjusted
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prevalence by age was greatest for dogs between 3-5 years of age. A similar age
association has been reported in populations with very high seroprevalence in endemic
areas of South America, where prevalence of infection was associated with increasing
dog age.22
Targeted surveillance to detect T. cruzi occurrence may be most effective in dogs
greater than 6 months of age with potential for vector exposure, however, identification
of young infected dogs may be important to minimize transmission and zoonotic risk.
The same study found that 100% of dogs less than 1 year of age were infectious to bugs,
while only 50% of dogs >7 years of age were infectious, and that young dogs infected a
greater number of feeding vectors.22 Although authors report that age may be a surrogate
for acuteness of infection rather than a true age association with infectiousness, young
dogs may contribute to parasite burden in vectors and transmission of disease if not
identified.
Future work will include confirmatory testing of positive samples using an
indirect fluorescent antibody (IFA) test for titer quantification. Results of the IFA will be
compared against categorical scores (strong, medium, or weak positive) based on the
color saturation of the immunochromatographic test to determine if color intensity
reflects titer and if weakly positive samples should be considered seropositive. Prior work
by other researchers found that only 4 of 11 faintly positive samples had detectable
antibody levels on an IFA.17 Our seroprevalence may therefore be an overestimate; if
only strong positives on the immunochromatographic test are positive by IFA, the
apparent seroprevalence of T. cruzi will decrease to 3.7%, with 1% of puppies and 5.3%
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of adult dogs in our sample being seropositive. This information may guide future
interpretation of immunochromatogrphic test results when determining seroprevalence.
Little information is available on the occurrence of T. cruzi in Mississippi. Our
study suggests widespread exposure in the shelter dog population, with potential for
exposure of owned dogs and humans in the state. Additional work is needed to determine
routes of infection within these populations and risk factors for disease. Although only a
single species of kissing bug, Triatoma sanguisuga, is reported to be widespread within
the state, seroprevalence is similar to Texas where numerous competent vectors are
present. Mississippi may, therefore, represent an important area of disease endemicity
within the United States. Veterinarians should consider T. cruzi as a differential in dogs
with chronic cardiomyopathy or for sudden death in young dogs when history suggests
possible exposure. Surveillance of clinical and seropositive canine cases within the state
may help identify risk factors for autochthonous Chagas’ disease in people.
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Footnotes
a. QGIS, Version 2.14, QGIS Development Team, Open Source Geospatial
Foundation, URL http://http://qgis.osgeo.org
b. PROC GLIMMIX, SAS for Windows, Version 9.4, SAS Institute Inc., Cary, NC,
USA
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CHAPTER V
CONCLUSIONS
Shelter dogs are a unique subset of the United States dog population, with
different risk factors and prevalence of disease than owned dogs. Knowledge of the
prevalence of disease in this population is necessary for the correct application and
interpretation of diagnostic tests and for effective allocation of resources within animal
shelters. Additionally, shelter dogs may be a useful population to assess public health
risks from zoonotic diseases such as canine brucellosis, in which dogs are the primary
reservoir, as well as effective sentinels for exposure risk for diseases such as American
trypanosomiasis.
In the second chapter, a cross-sectional study describes a census of animal
shelters in Mississippi and establishment of a serum bank. Many previous seroprevalence
studies have relied on convenience sampling, resulting in potential for bias and either
under- or over-estimation of disease. Random sampling eliminates many sources of bias
but requires an accurate sampling frame of animal shelters, which is not readily available
for much of the United States, including Mississippi. The census was a necessary first
step in order to quantify the shelter dog population in the state and to establish the
distribution of shelters and dogs in Mississippi. Based on this census, over 500 dogs were
randomly sampled from 18 shelters to represent the Mississippi shelter dog population.
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Sera from these dogs were banked for use in the studies reported in subsequent chapters
as well as for future seroprevalence research.
The third chapter reports an estimate of the seroprevalence of canine brucellosis
in the Mississippi shelter dog population. A previous study in Georgia found a small
number of dogs positive for B. suis, a highly zoonotic disease, following exposure to feral
swine. We demonstrated that shelter dogs do not pose a significant risk for transmitting
B. suis despite the presence of infected feral swine in Mississippi, but an estimated 7.4%
of shelter dogs are seropositive for B. canis. Additionally, this study is the first to report a
bimodal distribution of B. canis in animal shelters, with the majority of shelters having no
infected dogs and a small number of shelters having a much higher proportion of infected
dogs. This study also addresses diagnostic testing limitations by reporting true prevalence
of disease accounting for test sensitivity and specificity. The following appendices
contain educational material developed for the public and veterinarians regarding canine
brucellosis prevention and ongoing surveillance in the state.
The fourth chapter contains an estimate of the seroprevalence of T. cruzi, the
causative agent of Chagas' disease, in the Mississippi shelter dog population. Rare
autochthonous cases of Chagas' disease have been reported in dogs and people in
Mississippi, but little is known about the occurrence of disease in domestic dogs, insect
vectors, or wildlife mammalian hosts. We found 7.4% of dogs seropositive for T. cruzi,
with positive dogs identified in 8 of 9 geographic districts and 13 of 18 sampled shelters,
indicating widespread exposure in Mississippi. Additionally, we found that while older
dogs are at greater risk for being seropositive, a small proportion of young puppies were
also seropositive and may contribute to disease transmission through insect vectors.
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The research included in this thesis has important implications for dog and human
health in the state of Mississippi and beyond. Thousands of dogs are transported from
shelters in the state to adoption centers across the United States each year and may result
in dissemination of disease. The studies included in this thesis, along with future
seroprevalence research utilizing the serum bank, will assist in the development of
evidence-based public policy and disease control programs aimed at safeguarding animal
and human populations.
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APPENDIX A
WHITE PAPERS CREATED IN CONJUNCTION WITH THE MISSISSIPPI
BOARD OF ANIMAL HEALTH FOR PUBLIC EDUCATION ON
CANINE BRUCELLOSIS

121

122

Figure A.1

Canine Brucellosis: Information for Animal Shelters (Page 1)
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Figure A.2

Canine Brucellosis: Information for Animal Shelters (Page 2)
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Figure A.3

Canine Brucellosis: Information for Breeding Kennels (Page 1)
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Figure A.4

Canine Brucellosis: Information for Breeding Kennels (Page 2)
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Figure A.5

Canine Brucellosis: Information for Pet Owners (Page 1)
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Figure A.6

Canine Brucellosis: Information for Pet Owners (Page 2)

APPENDIX B
WHITE PAPERS CREATED IN CONJUNCTION WITH THE MISSISSIPPI
BOARD OF ANIMAL HEALTH FOR VETERINARY EDUCATION ON
CANINE BRUCELLOSIS AND CONTINUED SURVEILLANCE
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Figure B.1

Canine Brucellosis: Information for Veterinarians (Page 1)
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Figure B.2

Canine Brucellosis: Information for Veterinarians (Page 2)
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Figure B.3

Canine Brucellosis Surveillance: Case Report Form (Page 1)
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Figure B.4

Canine Brucellosis Surveillance: Case Report Form (Page 2)
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